TSS:Rfhg 14631.1

Basic information about the TSS

---

TSS ID: rfhg_14631.1 Species: human Chr: chr1		Start: 159924530 End: 159924602 Strand: -
Source datasets	PRJDB5282|DRA013844|PRJNA4843412
Protocol	C1CAGE|CAGE|NETCAGE
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2229506,EH38E1390004)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000320307.8:0 NM_001277223.2:0 GeneID: 8407 HGNC/MGI_ID: HGNC:11554 UniProt_ID: A0A384MTL2 Nearer transcript ids and distances: LF320820:-411 MA556397:-411 view more...

Gene_name: TAGLN2 Gene_symbol: TAGLN2 Gene_synonyms: HA1756 KIAA0120 Gene_source: HGNC:11554

TATA-Box annotation

---

Distance to TSS:	29
Nearest PromoterID:	NM_001277223
Entrez ID:	8407
Nearest Unigene:	Hs.517168
Nearest Refseq:	NM_003564
Nearest Ensembl:	ENSG00000158710
Gene Name:	TAGLN2
Gene Alias:	HA1756
Gene Type:	protein-coding
CpG%:	0.097222
GC%:	0.808219
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TAGLN2 p2@TAGLN2 p3@TAGLN2 p4@TAGLN2 p5@TAGLN2 p6@TAGLN2 p7@TAGLN2
Sample		p1@TAGLN2	p2@TAGLN2	p3@TAGLN2	p4@TAGLN2	p5@TAGLN2	p6@TAGLN2	p7@TAGLN2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	598.44	40.13	3.12	0.78	0.39	2.53	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	592.19	44.11	3.24	0.40	0.20	2.83	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	617.68	40.70	2.70	0.58	0.58	2.89	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	580.69	40.33	2.29	0.21	0.62	2.08	3.53
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	605.83	45.44	4.05	0.22	1.12	2.47	2.47
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	618.64	40.31	1.55	0.19	0.58	1.74	2.13
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	685.68	46.84	4.58	0.44	0.22	6.32	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	677.00	50.14	2.66	0.48	1.21	3.15	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	649.70	57.28	3.21	0.64	0.43	2.99	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	350.67	36.52	3.48	0.58	0.58	2.90	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	322.98	28.30	0.81	0.40	1.21	1.62	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	345.57	36.59	2.03	0.00	0.41	0.41	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	301.11	23.37	6.13	0.16	3.22	9.83	2.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	317.54	24.96	6.16	0.00	3.31	8.42	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	242.17	19.98	3.95	0.22	2.63	7.68	3.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	309.08	21.13	5.53	0.25	3.02	10.06	5.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	328.27	25.99	5.46	0.22	4.37	7.43	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	328.60	27.42	3.80	0.00	3.80	10.55	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	406.80	22.93	10.13	0.00	1.60	5.86	4.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	270.34	23.92	4.36	0.00	2.11	12.19	5.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	326.11	27.93	6.55	0.00	2.94	8.42	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	331.09	27.45	6.04	0.17	3.63	11.05	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	354.16	26.24	6.98	0.78	3.75	10.21	3.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	333.91	25.48	5.10	0.24	3.88	11.16	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	327.39	29.41	6.97	0.77	3.87	10.84	5.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	295.94	28.17	4.43	0.00	3.80	11.39	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	388.47	25.28	3.30	0.00	1.65	9.34	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	376.03	35.60	4.72	0.47	5.19	8.25	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	292.68	29.24	4.36	0.48	3.88	10.98	3.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	325.01	27.87	3.26	0.72	4.16	13.39	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	369.28	27.42	5.02	0.63	4.40	11.93	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	312.02	25.79	5.28	0.39	2.15	12.50	5.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	373.73	30.39	4.64	0.21	2.32	16.25	5.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	461.83	35.30	4.78	0.49	3.46	11.05	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	366.69	30.67	3.37	0.56	4.11	18.89	5.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	346.45	32.38	4.79	0.38	3.45	11.69	5.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	352.96	35.36	3.88	0.41	3.27	17.17	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	407.81	37.07	5.84	0.81	3.63	12.69	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	370.85	39.98	4.05	0.27	3.24	11.07	4.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	309.44	29.53	5.04	0.00	4.32	9.36	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	361.59	35.29	6.35	0.47	4.71	12.70	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	478.71	38.36	4.39	0.44	3.37	10.25	4.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	323.09	25.73	4.85	0.84	2.53	14.55	6.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	331.82	30.77	5.24	0.35	4.37	15.04	4.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	312.00	28.71	4.82	0.00	3.21	14.25	6.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	337.34	30.48	5.58	0.47	3.02	19.31	5.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	353.86	28.07	4.32	0.72	3.60	14.39	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	293.28	29.21	3.28	0.30	1.79	12.22	6.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	385.15	35.43	6.94	0.24	2.87	14.60	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	341.11	33.16	3.84	0.40	2.22	10.31	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	415.65	37.10	3.28	0.41	2.46	18.24	9.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	457.65	45.36	5.34	0.89	2.22	20.01	6.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	433.76	41.98	0.00	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	495.03	51.81	4.26	0.00	5.68	11.36	6.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	467.25	53.02	4.97	0.00	2.65	10.60	9.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	513.43	48.66	5.87	0.00	0.84	9.23	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	488.17	42.71	5.51	0.00	1.84	14.24	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	440.79	46.35	6.48	0.32	1.30	21.07	12.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	385.40	45.61	3.53	0.32	3.53	21.84	5.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	571.77	55.64	5.66	0.94	2.83	21.37	11.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	506.93	71.92	3.53	0.00	0.00	17.63	7.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	540.60	75.15	3.36	0.00	2.80	7.85	7.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	495.20	46.18	1.59	0.80	1.59	14.33	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	426.07	61.50	5.78	1.02	0.00	19.71	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	443.19	57.19	3.57	0.65	1.30	28.59	10.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	512.95	73.84	2.48	0.71	1.42	28.40	13.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	226.30	80.82	0.00	0.00	0.00	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	513.34	110.56	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	742.00	152.10	3.90	0.49	2.93	16.09	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	622.32	135.87	1.98	0.99	1.49	14.38	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	652.54	126.66	4.69	0.94	0.47	7.51	8.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	585.21	124.53	0.66	0.66	1.99	31.13	10.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	556.81	119.41	2.78	1.24	3.40	28.46	11.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	556.76	141.56	2.75	1.53	2.45	22.01	7.34
Adipocyte - breast, donor1	11376-118A8	243.59	11.40	3.96	0.00	2.06	2.53	1.27
Adipocyte - breast, donor2	11327-117E4	273.69	13.32	4.01	0.00	2.89	4.49	1.60
Adipocyte - omental, donor1	11473-119C6	217.30	11.20	2.54	0.25	1.27	2.16	2.04
Adipocyte - omental, donor2	11474-119C7	269.10	15.70	0.75	0.00	1.49	2.24	1.49
Adipocyte - omental, donor3	11475-119C8	98.47	8.71	0.67	0.33	1.34	1.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	266.68	17.23	0.00	0.00	0.64	1.91	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	238.59	29.69	1.10	0.00	1.10	5.50	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	371.24	37.03	2.71	0.00	0.45	1.35	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	155.53	8.69	3.82	0.00	0.52	0.70	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	260.50	19.75	2.35	0.20	4.11	0.98	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	319.92	24.97	3.35	0.51	2.06	1.54	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	404.50	33.17	6.13	0.00	3.35	0.84	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	308.01	28.80	1.76	0.00	1.18	0.59	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	132.80	9.81	2.82	0.00	0.72	0.97	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	258.53	17.75	0.97	0.00	1.29	2.90	2.26
Adipocyte differentiation, day08, donor3	13026-139E2	196.21	8.53	2.13	0.00	0.53	3.20	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	240.38	12.80	0.56	0.00	1.11	1.67	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	133.09	8.32	0.83	0.00	1.25	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	274.52	21.10	1.26	0.25	2.01	1.26	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	158.39	7.85	1.31	0.00	0.98	0.65	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	128.49	8.83	2.74	0.00	0.91	1.22	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	1133.28	100.11	6.63	0.66	5.52	1.99	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	1923.79	168.89	4.30	1.08	6.81	3.23	2.51
Alveolar Epithelial Cells, donor3	11671-122G6	791.89	67.09	2.40	0.00	5.99	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	1075.30	101.47	4.86	0.00	1.08	0.72	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	905.36	61.92	10.04	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	1376.09	94.71	9.04	0.00	2.47	3.90	2.88
Anulus Pulposus Cell, donor1	11248-116E6	476.47	29.06	8.01	0.69	6.18	1.03	0.34
Anulus Pulposus Cell, donor2	11463-119B5	288.99	17.88	1.71	0.00	5.14	0.73	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	376.96	51.22	3.59	0.00	1.80	2.70	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	480.16	57.31	3.91	0.00	1.74	0.87	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	616.39	38.52	2.14	0.00	0.00	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	382.92	42.45	4.18	0.00	2.39	1.49	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	414.81	46.79	1.26	0.00	3.79	2.53	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	611.23	38.94	1.98	0.00	1.32	3.30	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	449.64	49.71	2.92	0.65	1.95	1.30	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	453.89	59.71	5.34	0.00	1.46	1.46	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	635.45	37.41	4.16	0.00	6.53	8.31	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	437.65	52.73	3.01	0.00	4.52	2.26	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	377.35	50.80	5.08	0.00	1.45	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	562.95	38.87	3.76	0.00	1.25	7.52	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	594.04	41.02	4.12	0.16	3.13	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	318.00	31.39	5.46	0.00	4.09	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	355.87	41.92	2.41	0.15	1.96	1.66	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	402.38	50.90	4.29	0.00	3.75	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	493.12	49.88	2.46	0.19	3.97	1.70	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	705.64	51.05	6.41	0.80	3.21	2.14	3.21
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	285.81	35.12	3.90	0.00	2.93	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	446.66	49.59	2.82	0.17	3.98	1.49	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	642.39	26.42	1.20	0.00	2.40	7.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	240.73	17.70	3.54	0.00	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	449.75	46.31	4.46	0.00	3.60	1.72	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	776.07	33.56	0.00	0.00	12.58	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	392.71	56.31	2.91	0.49	1.94	0.97	3.40
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	513.40	55.02	4.55	0.00	3.42	3.04	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	609.32	41.19	7.27	1.21	6.06	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	385.34	54.15	1.71	0.00	1.14	1.14	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	483.13	42.54	3.21	0.00	2.78	2.78	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	522.63	41.29	3.61	0.26	3.61	2.32	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	448.56	62.87	3.28	0.00	3.28	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	475.25	48.55	2.57	0.00	3.54	2.89	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	645.67	55.65	7.13	0.00	1.43	4.99	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	414.73	57.33	2.92	0.58	4.68	2.34	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	520.55	49.68	4.22	0.30	4.22	3.01	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	645.08	45.14	5.94	0.00	2.38	13.07	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	491.27	62.55	3.56	0.00	3.56	2.03	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	529.75	51.45	2.80	0.51	4.08	6.62	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	583.90	46.38	3.18	0.00	3.81	3.81	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	425.06	60.41	3.02	0.00	1.29	3.02	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	482.01	49.96	4.23	0.00	3.60	3.60	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	574.16	41.47	4.64	0.00	3.19	5.51	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	393.96	32.12	3.78	0.00	3.78	0.94	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	487.55	45.77	3.39	0.51	4.07	1.36	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	625.42	39.38	6.95	0.00	4.63	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	259.85	33.80	6.34	0.00	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	485.21	58.32	2.79	0.43	3.65	3.00	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	680.48	34.29	6.62	0.60	4.21	3.01	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	420.62	67.79	4.37	0.00	1.46	2.19	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	570.10	58.39	3.91	0.46	4.83	2.99	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	627.37	33.15	0.00	0.00	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	380.08	31.27	2.29	0.00	3.81	1.27	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	571.01	64.82	2.68	0.00	4.75	2.68	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	565.18	34.27	1.84	0.31	3.67	2.45	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	428.78	51.63	2.87	0.00	3.35	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	506.01	51.89	3.10	0.00	3.99	2.22	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	608.79	42.72	0.00	0.00	7.63	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	393.26	58.71	0.55	0.55	1.66	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	488.55	42.37	3.44	0.00	3.18	2.12	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	527.36	36.71	3.27	0.36	2.54	1.09	3.27
Astrocyte - cerebellum, donor1	11500-119F6	605.85	49.25	2.95	0.00	2.33	0.37	0.49
Astrocyte - cerebellum, donor2	11580-120F5	745.74	53.06	4.11	0.00	3.77	2.57	1.03
Astrocyte - cerebellum, donor3	11661-122F5	206.18	11.33	3.99	0.21	1.05	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	474.77	48.10	9.06	0.00	6.62	1.39	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	900.76	49.50	10.68	0.16	5.18	4.21	2.43
Astrocyte - cerebral cortex, donor3	11392-118C6	776.38	60.56	7.76	0.30	4.77	2.39	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	554.28	48.63	13.65	1.49	0.80	2.29	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	542.72	54.00	13.03	0.75	0.25	1.50	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	516.86	41.76	10.81	1.02	0.11	0.68	1.48
Basophils, donor1	12241-129G9	675.80	67.21	3.14	127.10	6.80	1.57	0.00
Basophils, donor2	12242-129H1	753.34	41.85	2.89	88.76	2.53	0.00	0.72
Basophils, donor3	12243-129H2	635.91	54.09	4.70	93.64	3.97	1.76	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	569.62	52.39	2.80	0.00	1.08	0.43	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	1304.35	144.93	4.11	0.91	5.49	3.20	5.03
Bronchial Epithelial Cell, donor3	11672-122G7	954.08	50.21	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	1458.66	82.85	3.14	0.00	5.02	3.77	5.65
Bronchial Epithelial Cell, donor5	11457-119A8	1363.32	95.45	3.33	0.21	4.37	2.91	1.66
Bronchial Epithelial Cell, donor6	11461-119B3	575.73	56.19	2.53	0.23	2.99	1.15	4.38
Bronchial Epithelial Cell, donor7	11769-123I5	473.44	45.35	1.98	0.54	1.62	2.70	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	419.33	58.95	11.23	1.13	0.31	1.03	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	494.22	42.16	11.18	2.10	0.23	2.10	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	674.41	41.25	15.35	40.93	1.92	0.96	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1013.51	31.03	20.68	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	445.21	58.61	5.64	32.12	9.02	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	628.07	57.54	2.78	31.18	7.05	1.86	0.37
CD14+ Monocytes, donor3	11381-118B4	629.41	72.89	4.83	69.37	5.27	2.20	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	217.09	15.85	6.51	0.00	0.28	1.13	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	269.52	17.06	4.55	0.38	0.00	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	197.57	9.53	4.27	0.00	0.00	0.33	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	1290.68	66.78	5.78	4.63	3.61	8.38	6.22
CD14+ monocytes - mock treated, donor2	11873-125C1	837.64	46.17	3.92	3.92	0.91	4.83	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	1091.84	55.67	3.08	8.05	2.13	5.21	3.79
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	985.14	64.11	2.85	9.71	2.34	5.19	2.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	691.96	40.30	2.48	6.07	2.21	2.48	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	895.27	57.02	1.49	10.91	2.73	2.73	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	987.42	57.17	3.52	11.55	2.15	6.85	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	811.55	45.94	3.56	9.97	2.49	2.67	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1104.69	68.99	3.05	18.50	3.05	4.79	2.18
CD14+ monocytes - treated with Candida, donor1	11868-125B5	811.95	48.46	3.75	16.86	2.81	2.58	3.04
CD14+ monocytes - treated with Candida, donor2	11878-125C6	768.81	57.03	3.70	7.92	3.17	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1052.78	66.56	2.22	9.98	1.11	1.11	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1191.92	64.26	3.27	7.88	2.38	10.71	5.50
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	882.80	48.49	2.59	2.99	1.40	3.79	3.59
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1063.07	72.66	2.50	8.95	1.25	4.79	4.58
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1398.33	88.54	4.12	10.98	3.43	5.95	9.84
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	860.71	57.91	2.49	10.18	1.36	2.71	2.71
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1049.69	69.40	0.44	13.97	1.75	3.49	3.93
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1068.43	41.96	2.42	5.11	1.88	4.84	2.69
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1062.46	60.54	2.62	15.18	3.14	4.71	4.01
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1301.18	63.96	1.68	14.73	2.95	5.89	5.47
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1043.66	99.02	4.41	7.35	4.78	6.43	2.57
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	756.67	66.93	1.06	4.93	1.76	2.11	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1038.02	97.40	1.32	7.90	1.32	4.39	3.95
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	777.18	39.76	2.09	20.05	4.01	4.36	2.27
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	785.72	48.69	3.35	17.47	1.12	4.83	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1004.89	68.33	3.66	39.88	1.94	2.59	2.80
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1043.37	73.71	4.09	7.78	4.09	7.37	3.28
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	706.29	68.61	1.62	9.04	1.85	1.85	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	960.91	79.11	1.39	8.35	3.02	5.80	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	483.01	34.87	2.40	14.39	0.44	1.74	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	408.63	31.88	4.16	16.40	1.85	0.23	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	420.02	36.17	2.17	23.39	1.08	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	798.23	43.45	6.07	14.01	2.18	1.40	1.87
CD14+CD16- Monocytes, donor2	11799-124C8	690.19	50.30	5.41	12.92	1.92	2.10	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	606.48	34.34	3.79	14.27	1.78	1.56	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	302.38	28.58	3.06	13.52	0.77	0.26	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	216.27	16.69	3.07	9.44	0.66	1.98	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	288.24	24.00	4.21	14.74	0.42	0.84	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	910.47	71.13	10.16	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	932.22	94.92	1.36	10.85	0.00	1.36	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	939.29	88.03	6.21	8.28	0.00	1.04	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	763.84	89.55	3.20	25.59	1.07	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	845.38	87.92	2.14	11.79	0.00	2.68	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	899.18	99.68	3.51	9.13	2.81	0.70	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	989.86	90.99	3.92	10.98	1.57	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	905.66	126.56	6.59	15.82	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	1001.90	152.87	3.29	69.04	0.00	2.47	2.47
CD19+ B Cells, donor2	11624-122B4	922.02	126.95	2.90	50.05	0.00	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	860.22	133.78	1.51	63.61	0.50	4.04	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	201.22	9.29	1.62	0.81	0.40	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	161.39	11.98	2.40	0.40	0.80	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	822.32	63.26	7.03	45.18	5.02	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	1068.56	70.23	3.37	15.73	2.81	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	661.70	27.43	10.15	11.27	0.38	1.50	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	812.42	27.51	11.73	18.94	0.45	1.13	1.13
CD4+ T Cells, donor1	11225-116C1	404.19	62.48	4.28	43.56	0.00	0.71	1.07
CD4+ T Cells, donor2	11306-117C1	730.55	80.83	4.90	78.38	2.45	2.45	3.06
CD4+ T Cells, donor3	11382-118B5	874.42	95.46	5.18	105.53	0.30	3.35	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	394.34	32.93	3.57	1.28	0.26	1.28	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	423.14	36.83	4.27	2.47	0.00	2.02	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	371.69	28.17	8.34	1.44	0.29	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	501.59	50.25	6.64	38.88	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	481.09	50.57	4.92	49.86	0.00	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	514.21	56.04	9.89	42.85	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	473.58	43.93	4.34	8.09	0.14	3.47	2.60
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	500.08	34.91	6.44	3.73	0.00	4.91	2.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	431.55	33.85	5.16	8.06	0.48	3.06	2.42
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	730.28	65.90	4.48	26.00	0.45	3.59	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	773.89	68.48	3.49	34.59	0.00	3.49	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	654.25	48.84	2.20	33.88	0.00	3.96	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	471.39	37.10	3.79	4.22	0.00	0.84	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	497.19	39.48	6.65	6.65	0.00	4.78	2.91
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	490.17	26.40	7.02	8.35	0.33	5.35	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	496.55	45.14	6.53	76.14	0.00	1.36	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	413.75	41.27	5.36	72.89	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	477.00	35.86	5.38	68.14	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	566.85	47.10	9.09	5.93	0.00	2.04	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	413.52	31.19	5.42	4.55	0.22	1.30	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	358.31	22.28	8.62	6.30	0.21	3.57	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	704.81	75.84	6.07	64.72	0.00	2.02	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	737.83	114.81	6.50	94.45	0.43	1.30	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	669.41	63.19	6.10	83.68	1.31	0.87	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	868.50	55.92	8.91	5.94	0.00	4.45	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	659.15	59.08	4.62	5.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	728.62	62.81	9.77	6.98	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	805.86	81.14	1.66	26.86	0.55	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	694.21	67.48	1.96	4.91	0.00	0.98	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	930.16	29.26	7.70	9.24	3.08	3.08	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1005.24	64.46	9.67	10.74	0.72	4.66	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	875.31	56.78	9.69	5.54	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	472.43	105.75	5.57	60.24	0.98	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	550.01	83.35	4.88	64.95	1.50	4.13	1.13
CD8+ T Cells, donor3	11383-118B6	522.65	89.63	4.80	74.74	0.76	1.26	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	693.45	224.80	2.06	1.61	1.61	2.06	2.52
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	669.32	193.15	2.16	1.20	0.96	2.16	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	711.06	163.61	3.28	1.92	0.55	4.65	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	776.05	296.01	1.80	0.90	1.80	2.40	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	658.27	199.19	1.68	0.48	1.92	2.64	2.64
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	716.04	206.92	1.59	2.05	1.14	2.73	2.05
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	720.95	187.08	2.61	0.22	1.09	2.17	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	761.19	172.66	2.11	0.79	0.79	1.32	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	759.83	198.63	2.35	0.47	1.17	2.58	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	759.22	204.07	0.60	0.91	0.91	4.53	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	757.05	161.23	3.78	0.87	1.16	3.49	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	634.65	190.50	3.20	0.53	1.33	2.66	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	381.72	125.20	1.31	0.44	2.63	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	404.88	138.00	0.91	0.46	2.73	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	303.57	78.32	0.00	2.24	2.98	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	731.84	232.66	1.08	0.00	2.52	2.16	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	622.34	207.73	1.73	2.30	2.30	1.73	3.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	613.05	167.58	2.36	1.18	2.12	2.83	2.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	652.82	222.47	2.22	0.32	0.95	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	605.28	204.53	1.54	0.62	1.23	2.15	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	594.36	186.26	0.96	0.32	0.32	0.96	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	567.20	182.44	2.68	1.15	1.53	2.68	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	591.16	154.09	1.18	0.39	1.58	2.36	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	682.28	143.72	0.76	1.51	0.00	3.78	3.78
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	338.85	166.21	0.80	3.21	3.21	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	316.84	165.07	1.40	2.80	2.10	2.10	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	359.63	187.33	1.00	2.00	11.02	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	279.64	20.11	0.00	3.66	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	509.90	47.93	4.45	0.99	0.00	3.46	0.99
Cardiac Myocyte, donor3	11686-122I3	413.14	42.72	3.47	0.53	2.63	0.42	0.21
Chondrocyte - de diff, donor1	11261-116G1	446.16	46.45	0.69	1.04	5.20	3.47	7.28
Chondrocyte - de diff, donor2	11338-117F6	482.25	45.49	1.07	0.36	3.91	2.13	0.71
Chondrocyte - de diff, donor3	11410-118E6	449.54	29.81	4.89	0.11	6.26	4.66	1.93
Chondrocyte - re diff, donor2	11339-117F7	1186.21	137.87	7.16	0.90	5.37	0.00	2.69
Chondrocyte - re diff, donor3	11411-118E7	506.31	39.63	2.43	0.81	4.04	2.43	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	585.04	40.51	9.07	1.26	1.84	1.49	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	792.43	35.27	7.05	1.07	1.71	6.41	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	539.92	35.49	5.49	0.97	1.95	1.86	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	362.49	18.16	3.85	0.83	1.01	0.83	0.46
Corneal Epithelial Cells, donor1	11526-119I5	767.85	93.10	4.61	0.00	2.42	0.88	0.00
Corneal Epithelial Cells, donor2	11606-120I4	1376.50	71.67	5.69	0.00	1.14	4.55	2.28
Corneal Epithelial Cells, donor3	11687-122I4	1025.59	73.37	7.67	0.00	2.05	3.32	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	65.05	4.62	1.65	0.00	0.00	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	54.88	5.99	1.89	0.00	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	103.52	20.70	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	94.06	6.05	4.10	0.00	0.00	0.76	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2007.14	224.80	6.83	4.10	0.68	6.49	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1248.94	168.44	1.96	3.26	0.65	1.31	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1552.98	171.32	0.97	2.90	0.97	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	606.87	36.86	6.84	0.00	5.00	0.67	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	562.13	63.37	4.69	0.59	3.52	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	661.75	65.33	4.81	0.57	4.52	1.41	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	758.85	35.78	6.29	0.00	5.11	1.97	0.39
Endothelial Cells - Artery, donor1	11264-116G4	901.13	110.82	3.49	0.00	3.49	5.53	3.49
Endothelial Cells - Artery, donor2	11341-117F9	1197.10	99.05	5.88	0.00	5.41	8.00	6.35
Endothelial Cells - Artery, donor3	11413-118E9	886.89	68.90	6.31	0.18	5.43	2.63	2.45
Endothelial Cells - Lymphatic, donor1	11236-116D3	285.27	23.27	3.77	0.00	2.66	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	306.40	20.39	3.65	0.00	1.52	0.91	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	292.33	29.04	3.38	0.28	1.41	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	580.90	90.63	0.00	0.30	4.46	2.97	8.32
Endothelial Cells - Microvascular, donor2	11342-117G1	400.91	34.88	6.25	0.00	1.04	1.04	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	334.19	40.69	5.39	0.14	4.96	2.13	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	814.64	84.43	1.20	0.00	6.40	3.60	3.20
Endothelial Cells - Thoracic, donor2	11343-117G2	1187.14	101.16	6.29	2.10	5.77	4.19	4.72
Endothelial Cells - Umbilical vein, donor1	11243-116E1	454.00	38.39	5.96	0.37	2.98	1.74	2.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	319.38	22.38	4.56	0.00	3.69	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	435.26	26.87	6.23	0.24	4.03	0.98	0.85
Endothelial Cells - Vein, donor1	11267-116G7	866.78	89.86	3.41	2.28	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	740.41	56.58	4.89	0.00	6.29	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	785.03	84.31	5.81	1.41	4.71	2.36	1.26
Eosinophils, donor1	12244-129H3	1387.47	60.99	0.00	30.49	15.25	15.25	0.00
Eosinophils, donor2	12245-129H4	3331.88	496.73	6.60	158.43	21.45	4.95	1.65
Eosinophils, donor3	12246-129H5	3370.65	395.92	3.57	124.84	21.40	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	695.60	37.87	4.64	0.00	2.93	1.22	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	690.61	37.44	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	1724.49	48.81	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	470.45	33.25	3.28	0.00	1.23	6.16	3.28
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	339.20	41.93	2.85	0.00	3.18	11.93	11.61
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	586.11	31.20	2.93	0.22	2.71	12.89	7.91
Fibroblast - Aortic Adventitial, donor1	11245-116E3	902.08	67.55	7.88	0.24	4.12	7.28	8.13
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	351.82	34.39	2.32	0.41	5.19	1.36	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	436.54	32.38	3.27	0.21	3.48	3.59	3.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	456.37	22.66	1.58	0.26	1.05	1.84	5.80
Fibroblast - Aortic Adventitial, donor3	11401-118D6	746.12	45.18	7.97	0.00	2.66	5.98	5.32
Fibroblast - Cardiac, donor1	11268-116G8	650.50	58.06	4.99	0.00	1.36	4.08	2.27
Fibroblast - Cardiac, donor2	11345-117G4	828.44	89.44	3.03	0.76	5.31	3.79	0.76
Fibroblast - Cardiac, donor3	11417-118F4	924.22	82.64	8.99	0.47	5.36	5.20	4.42
Fibroblast - Cardiac, donor4	11452-119A3	276.43	10.31	4.85	0.91	2.42	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	456.22	41.12	0.89	0.38	2.54	2.41	2.41
Fibroblast - Cardiac, donor6	11460-119B2	584.55	22.59	1.97	0.30	3.49	3.18	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	225.91	17.55	1.47	0.00	0.54	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	205.36	14.24	2.16	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	1177.69	86.42	11.72	0.00	2.93	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	228.33	39.90	7.15	0.23	4.84	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	236.77	11.53	3.90	0.68	2.88	0.51	0.85
Fibroblast - Dermal, donor1	11269-116G9	228.68	25.12	2.35	0.00	1.64	2.11	1.41
Fibroblast - Dermal, donor2	11346-117G5	382.53	31.60	3.77	0.00	2.83	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	294.96	22.73	3.02	0.00	4.84	3.02	1.93
Fibroblast - Dermal, donor4	11450-119A1	199.19	20.46	1.24	0.00	2.15	0.57	0.79
Fibroblast - Dermal, donor5	11454-119A5	230.98	15.18	1.74	0.00	1.40	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	279.04	19.98	1.46	0.00	1.95	0.49	1.14
Fibroblast - Gingival, donor1	11237-116D4	328.38	16.66	8.12	0.00	6.25	0.62	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	601.55	35.11	4.72	0.26	4.45	5.76	5.24
Fibroblast - Gingival, donor2	11318-117D4	520.28	26.22	8.43	0.00	2.77	2.11	1.71
Fibroblast - Gingival, donor3	11394-118C8	282.42	11.89	4.93	0.00	5.41	0.77	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	230.63	21.82	3.12	1.04	2.08	3.12	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	259.72	14.98	3.00	0.18	2.82	3.70	2.82
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	781.98	50.67	12.16	0.47	7.64	1.56	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	810.55	39.62	7.03	0.00	7.98	4.87	2.84
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1037.82	58.58	7.41	0.00	4.59	1.76	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	737.66	38.90	7.31	0.29	5.12	2.78	2.49
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	827.94	41.04	8.04	0.27	4.23	3.95	3.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	729.79	36.86	7.57	0.33	3.40	3.73	2.74
Fibroblast - Gingival, donor9 (control)	11927-125I1	220.55	8.51	1.32	0.15	6.31	3.52	3.67
Fibroblast - Lung, donor1	11270-116H1	596.75	47.58	6.80	1.36	6.80	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	353.64	32.83	4.48	1.49	7.46	2.98	5.97
Fibroblast - Lung, donor3	11419-118F6	685.23	54.45	9.50	1.06	6.54	2.32	1.90
Fibroblast - Lymphatic, donor1	11506-119G3	928.82	64.14	3.33	0.00	8.33	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	328.68	18.18	0.00	0.00	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	533.44	37.22	4.48	0.00	9.24	0.28	1.40
Fibroblast - Mammary, donor1	11540-120B1	769.31	74.29	5.28	0.00	6.09	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	750.91	43.94	0.00	0.00	7.99	0.00	7.99
Fibroblast - Mammary, donor3	11701-123A9	440.76	23.83	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	356.52	18.04	6.98	0.00	3.30	1.36	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	409.69	24.88	5.92	0.00	2.58	0.46	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	297.11	11.02	4.59	0.00	5.81	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	502.98	41.60	3.05	0.00	6.49	1.14	3.05
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	548.89	31.59	8.37	0.00	4.86	3.24	4.05
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	228.12	17.40	2.78	0.12	3.94	1.28	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	827.56	65.99	6.41	1.11	3.87	2.43	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	496.80	40.03	5.28	0.20	7.31	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	392.90	20.71	6.68	0.00	3.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	301.27	11.07	3.95	0.79	3.16	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	734.45	42.67	1.59	3.97	2.78	0.99	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	258.43	25.22	1.95	0.00	4.09	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	331.30	25.62	2.17	0.00	2.17	1.58	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	784.03	55.06	3.01	2.71	3.91	1.20	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	494.09	40.48	1.08	0.00	6.26	0.54	1.94
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	614.97	35.94	2.78	2.02	2.78	2.78	0.76
Fibroblast - skin normal, donor1	11553-120C5	400.51	31.50	2.46	0.00	2.63	1.48	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	538.16	26.07	7.22	2.21	3.81	2.61	0.80
Fibroblast - skin normal, donor2	11561-120D4	643.46	48.62	2.21	0.20	3.32	1.21	2.01
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	895.23	52.59	4.23	2.12	4.53	3.93	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	330.72	23.61	3.31	0.08	5.38	1.49	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	441.39	41.54	0.34	0.17	1.71	1.03	2.91
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	698.90	50.91	2.30	2.96	2.30	2.30	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	807.01	58.80	3.62	0.21	4.15	2.45	2.13
Fibroblast - skin walker warburg, donor1	11554-120C6	797.86	75.91	5.74	0.00	4.39	2.02	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	512.02	41.71	5.02	0.31	2.67	5.65	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	753.87	34.86	2.61	0.00	1.74	6.10	7.84
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1360.86	81.13	5.72	0.00	4.85	5.20	9.53
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1311.87	97.07	4.68	0.00	4.68	8.07	4.68
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	850.35	58.00	4.85	0.00	3.07	1.53	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	176.84	28.33	6.12	0.77	0.77	1.53	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	269.90	34.46	6.38	0.00	0.00	5.10	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	126.37	14.26	2.85	6.56	0.29	5.71	4.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.78	3.03	2.21	0.00	0.28	4.14	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	61.42	4.79	2.05	0.68	0.00	3.42	4.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	92.13	9.51	1.39	3.57	0.20	2.58	5.35
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	28.81	4.76	1.59	0.00	0.00	2.38	4.23
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	49.57	4.57	2.28	0.00	0.00	3.26	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	59.26	8.40	1.33	1.77	0.00	1.33	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	106.42	17.81	1.84	0.28	0.00	0.42	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	115.14	15.15	2.22	0.49	0.37	0.74	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	219.47	22.83	4.30	0.54	0.00	1.07	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	484.80	72.97	5.33	0.74	1.36	3.35	2.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	470.10	68.66	4.57	1.25	3.05	2.35	1.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	576.77	48.59	5.90	1.02	3.05	2.64	3.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	447.91	34.91	6.85	1.37	0.91	1.37	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	262.96	37.25	2.74	1.00	0.87	1.37	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	352.78	33.66	4.59	1.31	2.40	0.87	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	365.80	30.73	8.27	0.89	0.00	0.59	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	211.57	29.73	3.50	0.48	0.64	0.79	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	279.50	30.39	5.59	0.22	0.89	0.45	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	407.50	25.00	7.46	0.60	1.41	2.62	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	266.68	30.20	4.92	0.51	0.51	1.19	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	334.83	22.35	5.50	0.71	0.71	1.24	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	322.57	20.39	10.51	0.42	1.66	0.94	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	342.75	30.57	7.34	0.85	1.88	0.85	2.05
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	197.18	20.47	4.20	0.00	0.77	0.33	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	244.68	15.72	6.07	0.25	0.67	0.25	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	253.39	23.07	3.68	0.41	1.43	0.41	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	311.73	25.17	9.08	0.21	1.44	1.65	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	178.01	21.44	4.84	0.23	0.69	0.69	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	366.72	19.68	8.67	0.67	2.17	1.00	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	325.14	14.99	8.60	0.44	1.54	0.88	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	195.80	16.97	6.64	0.25	0.98	0.98	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	275.72	16.05	6.16	0.32	0.65	1.13	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	257.85	16.04	7.70	0.64	1.28	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	230.73	20.75	5.78	0.47	1.80	1.14	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	398.45	26.10	11.23	0.32	1.74	1.27	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	412.65	21.29	8.82	0.00	1.22	0.91	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	297.73	31.57	4.81	0.21	1.46	1.67	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	306.06	21.96	9.66	0.22	0.88	1.98	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	379.30	17.96	6.73	0.28	2.52	2.24	2.81
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	261.37	29.16	5.74	0.37	1.20	0.65	1.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	483.20	26.74	8.56	0.53	2.14	1.87	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	500.48	27.08	7.96	0.15	1.07	1.99	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	328.89	31.87	5.70	0.00	0.78	0.91	2.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	277.85	17.62	8.13	0.27	0.81	0.81	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	372.20	19.73	9.22	0.74	0.92	2.21	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	388.18	22.59	7.46	0.22	1.32	1.97	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	166.61	13.88	7.93	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	463.28	35.22	6.33	0.40	1.45	1.71	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	475.34	36.32	4.04	0.20	2.42	3.03	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	211.97	14.74	7.37	0.25	1.27	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	94.75	25.48	1.00	0.00	0.00	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	51.15	12.79	0.62	0.15	0.00	0.15	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	67.10	18.00	0.82	0.20	0.20	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	110.78	23.78	1.88	1.25	0.00	1.56	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	126.58	18.65	0.57	0.28	0.00	1.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	88.55	15.68	0.46	0.00	0.46	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	254.90	22.27	0.00	0.00	0.00	2.47	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	236.34	22.05	3.09	0.39	0.00	2.71	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	341.75	19.25	3.21	0.00	0.00	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	114.76	12.17	1.74	1.74	0.00	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	132.14	10.74	1.63	0.33	0.65	3.91	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	156.90	17.30	0.41	0.00	0.00	3.29	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	99.97	16.66	6.66	0.00	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	126.96	11.75	1.12	0.84	0.28	2.24	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	155.25	21.57	1.96	0.00	0.33	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	118.28	12.58	1.68	0.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	140.59	13.36	5.09	0.00	0.00	0.64	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	163.38	16.64	1.02	0.00	0.00	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	133.64	8.35	4.18	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	149.47	11.45	6.30	0.57	0.00	2.29	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	163.09	12.73	1.78	0.00	0.59	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	140.61	18.64	1.69	3.39	0.00	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	156.98	16.15	0.83	0.00	0.41	2.49	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	83.77	7.36	1.84	0.00	0.00	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	152.79	15.81	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	102.25	8.07	1.15	0.00	0.38	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	131.69	9.45	2.28	0.33	0.33	2.28	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	141.13	6.02	0.00	0.67	0.67	4.01	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	117.51	11.94	1.16	0.00	0.77	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	175.62	14.38	1.71	0.68	0.68	2.05	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	136.66	17.39	0.00	0.00	2.48	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	69.83	7.55	1.89	0.00	0.00	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	107.42	9.66	4.83	0.60	0.00	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	115.47	8.65	3.05	1.53	0.00	1.02	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	82.16	6.38	1.99	0.00	0.80	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	97.68	11.84	2.96	0.99	0.00	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	94.44	11.80	4.72	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	107.35	13.42	2.33	0.58	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	84.70	4.83	1.76	0.44	0.00	1.32	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	78.84	8.48	0.85	1.70	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	84.76	7.16	1.79	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	85.89	4.85	0.97	0.00	0.00	1.94	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	450.81	46.79	3.42	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	233.69	18.71	3.74	0.00	1.66	2.49	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1141.32	61.84	6.75	0.00	6.75	3.37	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	379.64	26.32	4.76	0.95	3.49	1.90	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	306.20	19.22	2.92	0.00	2.51	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	887.49	51.64	10.10	0.12	1.74	2.79	1.62
Hep-2 cells mock treated, biol_rep2	11899-125E9	913.05	48.61	11.14	0.17	1.86	4.56	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	758.04	53.92	11.60	0.00	1.37	1.14	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	877.86	46.24	16.29	0.33	2.40	4.26	2.62
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	888.88	51.36	10.53	0.00	2.15	2.36	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	691.70	38.54	9.47	0.22	1.08	1.08	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	927.43	54.92	15.07	0.12	2.62	3.49	1.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	873.87	50.78	11.49	0.00	2.40	2.57	2.06
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	695.85	52.22	5.77	0.32	2.56	2.56	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	381.10	25.18	3.36	0.00	1.68	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1010.57	83.10	12.98	0.00	3.90	2.60	2.16
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	927.98	31.73	7.93	0.00	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	497.34	37.39	4.59	0.00	4.59	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	730.14	43.59	5.09	0.00	0.73	2.18	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	996.06	73.78	7.87	0.70	2.97	2.97	1.05
Hepatocyte, donor1	11523-119I2	221.54	8.47	3.63	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	648.56	23.70	3.23	1.08	1.08	5.39	2.15
Hepatocyte, donor3	11684-122I1	197.56	8.59	1.23	0.61	1.23	0.00	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	377.91	21.54	7.83	1.31	0.65	1.31	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	404.97	22.02	3.67	0.00	0.00	2.10	1.75
Iris Pigment Epithelial Cells, donor1	11530-119I9	446.20	36.77	4.94	0.00	1.78	0.82	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	738.66	73.23	3.18	3.18	3.18	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	720.93	113.48	20.03	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	893.75	81.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	686.65	53.99	5.54	8.31	5.54	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	880.94	90.10	7.51	7.51	7.51	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1614.08	59.34	11.87	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	650.98	46.13	12.81	15.38	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	836.45	105.13	13.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	834.90	64.97	12.99	16.24	8.12	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	823.65	51.69	8.34	11.67	5.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	787.83	76.24	7.26	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	821.88	41.03	2.65	7.94	9.26	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	729.49	80.93	11.09	4.43	6.65	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	1084.32	104.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	579.47	66.14	6.30	6.30	3.15	4.41	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	708.35	72.69	4.64	4.64	9.28	3.09	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	585.39	58.54	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	606.63	71.06	7.11	3.88	4.52	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	763.10	61.18	6.44	9.66	6.44	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	621.31	83.64	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	558.19	53.78	8.96	2.44	4.89	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	721.23	62.97	14.69	2.52	3.78	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	416.80	43.12	0.00	14.37	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	507.93	47.42	12.86	2.41	3.21	5.63	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	733.09	55.40	11.08	0.92	1.85	2.77	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	497.67	45.24	15.08	30.16	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	601.38	70.81	10.38	0.94	0.94	5.19	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	696.56	52.60	14.51	2.72	0.00	4.53	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	471.76	58.97	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	572.50	74.25	10.76	1.08	1.08	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	782.61	64.79	6.35	2.54	0.00	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	591.49	98.58	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	480.81	56.12	8.93	1.91	5.10	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	657.98	76.55	5.47	1.82	3.65	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	616.37	47.41	15.80	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	467.71	42.84	7.85	0.71	2.14	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	739.98	56.41	13.27	0.00	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	291.88	125.09	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	531.82	56.79	7.41	0.31	1.54	2.47	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	672.56	77.26	14.05	1.76	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	634.91	56.58	12.57	3.14	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	479.12	54.94	8.34	0.00	4.17	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	774.58	64.18	11.07	2.21	4.43	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	852.65	84.29	6.48	0.00	0.00	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	588.55	74.11	10.46	1.74	3.49	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	866.17	53.99	13.50	0.00	2.25	6.75	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	738.73	62.72	10.45	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	518.45	49.07	9.60	0.00	7.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	652.54	63.73	8.31	0.00	2.77	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	535.72	62.69	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	552.26	62.59	11.97	1.84	0.00	1.84	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	632.29	60.51	6.05	0.00	0.00	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	546.36	62.09	0.00	6.21	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	488.51	57.10	13.75	0.00	6.34	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	873.60	39.58	4.24	0.00	2.45	2.86	4.08
Keratinocyte - epidermal, donor2	11349-117G8	436.30	45.68	2.34	0.00	1.17	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	786.78	71.94	4.64	0.09	1.99	3.03	1.42
Keratinocyte - oral, donor1	11251-116E9	728.78	61.87	6.70	0.34	1.36	1.14	1.14
Keratocytes, donor1	11527-119I6	223.83	26.13	1.38	0.00	4.81	0.34	0.34
Keratocytes, donor2	11607-120I5	645.66	58.59	5.86	0.00	3.52	1.17	3.52
Keratocytes, donor3	11688-122I5	226.64	21.14	0.79	0.00	1.38	1.98	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	283.53	8.79	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	742.18	71.20	3.24	0.00	1.08	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	357.07	35.98	6.69	0.46	3.34	0.69	0.23
Lens Epithelial Cells, donor3	11690-122I7	334.52	30.47	3.73	0.40	0.61	0.40	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	442.88	43.40	6.17	0.12	3.91	1.78	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	567.92	49.12	5.58	0.56	1.95	3.07	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	418.24	37.46	5.35	0.16	2.52	2.68	2.20
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	481.79	62.91	3.23	0.54	1.61	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	487.88	35.93	4.41	0.63	2.52	4.10	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	457.89	41.72	4.64	0.22	4.42	2.37	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	414.91	44.32	4.51	1.23	3.69	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	671.24	57.64	8.09	0.51	4.55	2.53	2.78
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	475.45	39.13	5.35	0.14	3.80	1.69	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	445.77	51.02	2.37	0.00	1.58	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	596.58	44.59	6.40	0.19	3.88	1.55	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	534.89	44.99	5.00	0.19	4.26	3.52	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	449.47	49.13	6.27	0.70	5.92	1.74	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	616.58	51.52	5.96	0.00	3.34	2.39	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	512.86	39.69	5.49	0.14	3.43	2.06	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	434.84	47.12	4.31	0.31	2.16	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	635.33	48.94	5.61	0.31	4.36	1.87	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	532.50	44.10	4.57	0.37	3.29	2.56	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	420.93	45.75	5.59	0.33	3.62	1.65	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	676.53	55.06	5.56	0.00	3.81	2.05	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	640.00	50.78	3.24	0.25	4.23	1.99	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	435.50	52.38	2.91	0.00	3.88	2.42	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	592.18	52.51	5.39	0.00	5.92	2.15	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	445.05	41.17	6.21	0.76	3.18	1.21	1.67
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	421.47	46.66	3.11	0.00	2.59	1.04	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	619.38	52.77	5.23	0.00	3.56	3.14	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	473.67	40.60	4.36	0.00	3.01	2.71	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	491.83	48.15	0.69	0.00	4.13	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	565.20	49.48	5.64	0.19	3.20	2.45	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	466.32	40.82	5.41	0.32	3.50	2.01	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	412.38	51.37	3.39	0.00	3.39	2.42	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	607.66	39.69	5.95	0.00	3.31	1.98	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	486.65	43.98	5.95	0.37	3.47	1.73	1.36
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	395.38	32.95	2.59	0.00	2.22	0.37	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	565.57	40.03	4.69	0.49	6.18	1.24	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	530.45	49.36	5.36	0.41	2.75	2.47	1.79
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	388.22	37.31	6.11	0.32	4.18	0.96	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	609.88	47.78	7.91	1.22	3.04	3.04	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	504.58	42.55	5.46	0.28	3.22	2.10	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	419.92	45.16	4.27	0.36	2.13	0.71	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	691.78	55.75	6.79	0.00	4.36	2.42	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	531.56	42.79	5.45	0.16	3.27	1.87	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	444.77	60.16	6.45	0.36	2.86	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	647.80	45.41	6.86	0.00	2.61	1.96	3.27
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	504.75	39.79	4.47	1.41	3.30	2.59	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	430.41	38.73	4.46	0.00	2.85	2.60	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	641.09	49.18	5.89	1.28	2.82	1.79	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	430.53	58.78	2.69	0.30	2.69	2.39	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	373.89	4.53	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	380.50	26.85	4.60	0.00	0.00	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	353.30	25.24	2.97	0.00	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	508.18	14.39	4.65	0.00	0.42	2.54	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	400.19	18.29	4.22	0.00	0.70	5.63	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	440.83	14.01	4.67	0.00	1.87	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	432.83	15.97	2.06	0.52	1.03	5.15	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	412.74	15.46	2.38	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	325.72	14.93	4.75	0.23	0.23	1.58	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	471.72	16.87	2.33	0.29	0.87	5.82	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	420.01	25.66	1.80	0.45	1.80	2.25	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	462.96	18.56	3.93	0.14	0.54	1.90	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	435.47	12.84	4.11	1.54	0.51	3.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	380.73	23.29	3.88	0.35	0.71	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	386.46	29.98	3.33	0.00	1.33	0.67	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	420.24	12.23	4.08	0.51	1.53	4.08	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	412.48	25.08	2.93	0.00	0.27	1.33	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	432.87	19.46	2.83	0.38	0.19	3.59	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	436.24	14.73	1.23	0.00	1.23	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	429.73	22.02	3.26	0.82	1.63	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	425.65	17.28	2.08	0.21	0.62	4.37	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	414.79	13.17	2.24	0.28	0.56	6.45	2.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	390.50	28.85	0.00	0.00	0.00	5.15	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	425.88	13.93	4.94	0.00	0.29	3.19	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	414.02	15.54	3.89	0.30	0.90	2.09	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	401.11	21.58	2.21	0.55	0.00	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	423.48	17.32	2.83	0.35	0.71	2.83	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	438.11	14.38	1.48	0.00	0.00	4.06	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	377.62	13.82	3.45	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	467.03	21.11	3.07	0.38	0.77	1.54	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	443.28	17.55	3.96	0.57	0.00	6.23	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	428.28	19.69	3.28	0.00	0.82	3.28	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	451.43	16.72	1.36	0.45	0.90	3.16	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	498.39	18.67	0.00	0.00	0.00	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	470.55	25.39	4.48	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	468.58	15.24	2.23	0.00	0.74	4.83	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	463.05	15.51	3.02	0.86	0.43	5.60	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	374.20	16.27	2.57	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	505.43	19.99	3.33	0.33	0.00	3.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	487.47	13.88	3.62	0.00	1.21	4.22	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	389.63	19.20	3.55	0.00	0.00	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	441.33	16.50	3.78	0.00	0.69	3.78	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	512.06	15.57	2.68	0.00	1.07	4.83	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	398.63	14.14	2.69	0.00	0.67	2.02	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	494.12	20.37	3.33	0.00	2.22	5.93	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	407.03	9.30	2.33	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	412.52	24.33	1.06	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	457.37	13.20	1.60	0.00	0.80	2.00	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	453.57	14.54	2.91	0.73	1.45	2.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	437.68	23.00	1.53	0.77	0.77	2.30	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	437.54	20.22	2.47	0.99	0.99	2.47	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	420.60	15.05	1.88	0.00	0.94	1.88	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	404.27	18.60	3.02	0.50	1.01	2.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	403.76	22.98	2.25	0.00	0.45	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	509.45	8.61	1.72	1.72	0.00	3.44	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	398.58	23.60	1.34	0.00	0.45	3.12	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	449.29	18.38	2.35	1.17	1.17	2.35	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	447.30	18.47	1.98	0.00	0.66	0.66	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	420.85	22.31	4.67	0.00	0.52	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	424.88	17.50	4.38	0.44	0.00	1.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	432.74	13.98	1.68	0.56	0.56	5.59	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	410.29	18.99	3.09	0.00	0.88	1.77	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	447.04	15.04	2.70	0.39	2.31	3.86	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	469.90	18.23	3.54	1.01	1.01	3.54	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	428.23	21.63	2.88	0.00	0.00	3.36	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	473.88	19.48	3.18	0.40	1.19	2.78	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	391.92	18.23	0.61	0.61	1.82	3.65	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	351.38	20.75	1.38	0.00	0.00	1.38	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	438.89	16.34	2.66	0.00	0.00	5.32	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	429.66	12.91	2.58	0.00	1.03	5.16	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	360.98	21.16	2.42	0.00	0.00	1.81	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	413.24	16.48	1.58	0.00	0.32	4.12	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	402.48	14.93	3.73	0.00	0.53	2.13	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	375.83	17.24	1.72	0.00	0.57	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	437.10	20.06	1.03	0.00	0.00	4.11	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	526.98	14.85	0.71	0.00	0.00	4.24	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	405.75	24.40	1.70	0.00	0.00	1.13	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	442.23	19.55	1.66	0.42	1.25	2.08	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	519.16	15.66	1.57	0.00	0.78	5.48	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	431.33	19.21	1.25	0.42	0.42	1.25	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	442.80	17.19	2.32	0.00	0.93	4.18	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	471.01	14.72	1.34	0.67	0.67	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	453.91	22.45	1.60	0.00	0.53	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	426.73	19.80	5.25	0.00	0.40	2.02	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	405.65	13.77	0.92	0.00	0.92	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	441.00	24.90	0.89	0.00	0.00	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	449.63	11.97	3.42	0.00	1.14	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	493.88	14.57	3.07	0.00	2.30	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	486.44	26.81	0.00	0.00	0.55	2.19	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	431.64	23.16	1.34	0.00	0.45	2.23	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	454.66	18.72	1.82	0.26	1.04	2.08	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	500.65	25.86	2.65	0.00	0.66	3.32	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	561.22	16.63	4.16	0.00	0.00	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	161.14	9.34	4.56	0.00	0.46	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	299.85	19.64	5.32	0.55	0.55	0.55	0.55
Macrophage - monocyte derived, donor3	11389-118C3	329.54	21.50	7.21	0.13	1.05	0.26	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1364.19	71.16	4.78	0.00	2.66	2.12	3.19
Mallassez-derived cells, donor2	11929-125I3	1541.26	82.08	3.64	0.16	3.01	3.96	4.60
Mallassez-derived cells, donor3	11930-125I4	1544.43	119.11	4.45	0.00	4.45	5.00	4.31
Mammary Epithelial Cell, donor1	11273-116H4	343.47	37.96	4.98	0.40	5.98	1.10	0.90
Mammary Epithelial Cell, donor2	11350-117G9	563.17	65.44	4.05	0.29	2.61	1.16	1.45
Mammary Epithelial Cell, donor3	11422-118F9	727.33	40.41	6.49	0.00	4.49	1.25	1.25
Mast cell - stimulated, donor1	11487-119E2	666.41	36.61	7.46	0.68	4.07	0.00	0.00
Mast cell, donor1	11563-120D6	509.13	33.42	9.95	1.84	4.97	2.60	3.24
Mast cell, donor2	11565-120D8	1871.31	147.10	13.97	78.16	13.37	21.69	22.29
Mast cell, donor3	11566-120D9	1365.83	132.37	15.08	96.80	11.71	16.21	8.33
Mast cell, donor4	11567-120E1	1918.98	155.48	12.94	78.01	11.70	19.15	17.02
Mast cell, expanded and stimulated, donor5	11940-126A5	750.41	50.46	6.76	2.44	4.10	4.10	3.55
Mast cell, expanded and stimulated, donor8	11942-126A7	705.09	16.34	4.09	1.17	1.17	6.42	8.76
Mast cell, expanded, donor5	11939-126A4	699.92	43.82	8.95	1.61	5.28	5.28	4.02
Mast cell, expanded, donor8	11941-126A6	848.05	43.01	10.21	1.51	4.52	10.88	9.54
Melanocyte - dark, donor1	11502-119F8	198.80	16.12	4.97	0.90	4.58	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	508.05	46.03	4.15	2.08	1.38	2.77	0.35
Melanocyte - dark, donor3	11663-122F7	325.62	19.49	8.19	0.22	1.88	0.58	0.14
Melanocyte - light, donor1	11274-116H5	252.47	19.98	7.05	0.24	2.12	1.18	1.41
Melanocyte - light, donor2	11351-117H1	249.78	14.33	8.19	0.00	1.36	0.00	2.73
Melanocyte - light, donor3	11423-118G1	327.81	27.75	9.54	0.00	1.73	2.60	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	385.58	29.99	7.81	0.00	0.42	1.35	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	321.92	5.11	7.53	0.00	1.61	1.34	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	194.46	6.96	4.29	0.00	0.54	0.27	1.34
Meningeal Cells, donor1	11493-119E8	814.08	58.06	3.97	0.12	1.24	0.25	0.25
Meningeal Cells, donor2	11573-120E7	315.15	13.20	0.88	0.44	0.88	0.44	0.44
Meningeal Cells, donor3	11654-122E7	938.90	41.97	10.02	0.49	1.63	2.61	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	345.04	31.37	7.98	0.29	2.85	1.71	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	369.42	31.20	2.92	1.11	0.91	1.51	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	374.54	22.34	7.88	0.00	5.26	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	693.33	49.71	11.77	0.00	7.85	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1179.74	72.48	17.22	0.72	3.59	8.61	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	192.07	9.32	1.69	0.00	1.06	0.85	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	270.42	8.54	4.02	0.50	1.01	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	421.71	33.18	8.13	0.22	1.54	1.32	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	683.83	54.79	7.31	0.00	0.73	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	547.11	43.38	6.34	0.20	3.07	1.23	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	224.10	15.79	1.52	0.28	0.97	0.00	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	343.10	26.02	3.72	0.37	1.12	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	247.49	19.60	3.16	0.39	2.76	0.66	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	194.66	21.66	3.26	0.00	2.08	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	191.51	18.68	2.34	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	605.18	43.55	11.53	0.64	5.76	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	833.30	72.31	11.70	0.35	6.03	2.84	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	243.30	29.71	3.13	0.31	2.81	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	732.95	79.83	8.71	0.00	1.45	2.90	1.45
Mesothelial Cells, donor1	11247-116E5	967.89	88.83	5.57	0.53	4.77	6.10	6.89
Mesothelial Cells, donor2	12156-128G5	946.38	59.56	5.00	0.00	4.00	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	1175.31	85.49	5.56	0.79	4.48	7.52	6.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	89.12	2.70	2.70	0.00	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	122.89	10.84	5.42	0.25	0.00	0.99	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	161.95	6.77	4.71	0.00	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	110.63	3.46	10.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	123.36	7.75	4.65	0.00	0.00	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	174.45	10.58	6.02	0.00	0.83	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	64.85	2.32	6.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	145.15	10.26	4.00	0.25	0.75	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	167.11	6.98	5.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	147.94	12.80	3.25	0.20	0.20	1.22	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	178.98	8.71	4.36	0.00	0.79	1.19	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	179.58	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	137.17	10.62	4.42	0.00	0.00	2.65	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	229.48	10.26	4.56	0.00	0.38	1.14	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	107.90	1.32	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	141.34	13.16	3.82	0.00	1.06	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	106.82	4.60	3.68	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	109.98	12.52	4.17	0.00	0.89	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	85.51	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	153.80	12.55	3.26	0.00	0.75	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	159.71	5.23	3.09	0.00	1.43	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	105.60	7.19	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	153.80	14.51	3.68	0.00	1.15	1.15	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	130.83	7.36	4.21	0.00	0.21	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	161.02	15.29	2.85	0.41	1.63	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	140.09	15.02	2.15	0.00	0.43	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	136.04	7.56	2.67	0.00	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	123.82	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	135.13	14.89	3.29	0.00	0.66	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	87.70	3.04	3.04	0.00	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	106.05	9.94	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	111.16	11.96	2.17	0.00	0.54	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	128.51	5.00	2.35	0.00	0.29	1.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	89.41	3.27	2.18	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	148.01	13.94	3.36	0.00	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	151.29	7.60	1.60	0.00	0.80	4.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	98.73	8.23	0.00	0.00	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	172.70	29.03	4.00	0.00	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	67.27	4.08	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	160.72	21.02	1.75	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	75.05	5.52	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	81.97	5.12	1.92	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	185.20	27.27	1.49	0.25	0.74	0.50	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	90.47	5.57	2.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	108.28	6.63	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	260.85	40.68	2.39	0.00	3.08	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	99.78	5.69	1.31	0.44	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	79.19	15.62	1.07	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	238.19	42.36	1.96	0.28	0.84	1.40	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	159.60	15.38	0.83	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	123.54	11.07	1.17	0.00	0.00	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	188.84	28.96	2.41	0.00	0.30	0.90	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	201.18	23.79	1.67	0.00	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	187.48	30.48	2.77	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	170.74	13.66	2.28	0.00	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	135.97	26.39	1.24	0.28	0.55	0.69	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	227.01	39.39	1.30	0.26	1.30	1.30	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	175.02	14.59	0.43	0.00	1.72	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	123.23	10.16	3.81	0.64	3.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	145.45	23.75	2.67	0.27	0.80	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	259.22	33.23	1.20	0.30	1.50	1.80	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	138.57	24.15	0.71	0.00	1.27	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	268.19	48.73	2.87	0.00	0.64	1.59	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	224.23	20.79	1.55	0.22	0.66	0.44	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	168.36	17.06	3.41	0.00	2.65	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	226.72	34.95	1.42	0.00	1.14	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	269.65	27.28	1.23	0.00	1.23	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	161.61	19.55	0.65	0.00	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	227.58	34.11	1.47	0.00	0.59	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	317.16	36.33	1.44	0.29	2.31	2.02	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	314.47	24.32	1.65	0.00	2.47	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	287.06	42.88	2.08	0.30	0.89	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	259.91	26.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	196.05	7.13	7.13	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	244.13	18.40	5.59	0.00	0.00	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	274.56	5.26	3.16	0.00	0.00	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	106.16	6.13	4.15	0.00	0.20	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	142.49	6.52	5.59	0.00	0.93	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	125.05	5.63	4.51	0.00	0.00	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	157.94	8.52	3.46	0.00	0.27	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	165.58	13.12	3.96	0.00	0.23	0.45	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	212.91	5.89	5.16	0.00	0.74	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	186.51	13.92	3.66	0.00	0.00	2.56	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	196.01	24.89	3.11	0.00	0.00	4.67	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	309.97	22.45	3.74	0.00	0.00	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	243.43	15.46	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	255.51	15.15	7.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	270.69	16.44	6.75	0.00	0.42	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	309.16	31.32	4.09	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	338.88	20.35	3.81	0.00	1.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	359.57	38.06	5.67	0.00	0.00	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	291.51	27.19	6.04	0.00	1.51	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	148.46	125.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	274.05	81.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	156.83	33.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	939.30	69.15	3.88	0.43	2.80	3.23	2.59
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	587.42	27.18	4.70	0.00	1.57	3.14	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	488.60	40.05	8.68	4.00	1.33	2.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	303.01	17.53	2.92	0.42	2.09	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	565.10	38.41	6.65	0.57	2.28	9.70	2.85
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	595.25	15.96	3.19	1.60	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	280.14	12.24	1.36	2.04	3.40	4.76	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	327.10	31.24	5.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	213.87	11.72	3.35	0.84	1.26	5.02	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	272.88	16.04	3.72	0.23	2.32	3.25	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	261.04	18.65	2.70	0.27	1.62	2.70	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	269.52	14.30	2.52	1.05	1.05	1.05	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	345.18	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	326.60	21.34	3.47	1.99	3.97	3.47	4.96
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	160.24	9.20	2.44	1.08	0.81	3.79	1.89
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	142.58	11.33	1.59	1.59	1.13	2.27	2.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	151.22	8.49	1.31	2.12	0.82	2.12	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	220.71	15.49	1.64	0.91	2.55	1.46	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	174.51	11.67	1.59	2.65	1.06	0.53	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	166.88	16.21	1.20	1.80	1.20	2.40	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	198.22	9.52	0.98	0.66	0.66	3.28	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	87.33	5.85	0.81	1.63	1.79	3.25	1.63
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	198.43	14.11	1.59	1.76	2.82	1.06	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	141.35	12.66	1.41	1.41	0.70	1.41	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	160.90	11.49	1.84	0.46	1.38	5.98	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	152.00	12.21	0.96	0.96	1.29	4.18	2.57
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	165.55	11.04	2.07	1.03	1.03	4.48	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	242.73	37.93	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	144.59	8.47	1.11	0.67	1.56	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	108.81	11.01	1.27	1.69	1.69	2.12	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	149.53	12.82	0.71	0.24	1.66	5.46	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	170.41	17.60	2.15	1.72	1.72	2.58	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	127.62	9.66	0.67	1.00	0.67	0.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	136.16	5.41	2.25	0.45	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	145.63	8.33	0.40	1.19	0.40	2.38	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	210.80	13.93	1.86	0.93	1.86	2.79	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	140.75	9.46	1.51	1.89	2.27	4.54	2.27
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	136.87	11.08	0.65	1.63	0.33	1.96	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	69.29	6.54	0.87	1.31	1.74	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	147.90	9.50	0.90	0.00	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	126.99	15.87	0.88	0.00	0.88	2.65	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	180.84	22.60	1.99	0.00	0.66	1.99	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	160.72	9.42	0.99	0.99	0.50	0.50	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	101.45	9.19	0.38	1.15	0.38	1.91	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	106.76	11.19	1.81	0.91	0.91	1.81	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	225.67	14.15	1.11	1.55	0.66	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	104.36	4.07	2.03	2.03	0.00	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	25.55	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	121.33	10.97	1.83	0.61	1.83	2.44	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	86.55	7.87	1.26	0.31	0.31	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	71.12	5.45	1.51	1.82	0.30	0.91	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	195.41	13.45	2.37	6.33	0.79	2.37	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	171.18	12.47	1.13	1.13	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	151.74	20.23	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	621.02	41.12	6.09	0.12	3.23	1.86	1.24
Myoblast, donor2	11322-117D8	567.69	16.30	4.22	0.00	2.88	3.84	1.53
Myoblast, donor3	11398-118D3	600.68	39.18	9.08	0.00	4.54	1.35	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	359.29	41.30	3.36	0.00	0.29	0.88	0.58
Natural Killer Cells, donor1	11230-116C6	505.56	97.18	5.84	70.42	1.85	2.15	0.92
Natural Killer Cells, donor2	11311-117C6	540.69	100.12	5.73	72.37	2.41	2.41	0.90
Natural Killer Cells, donor3	11387-118C1	597.07	106.75	5.52	89.63	2.02	1.84	1.84
Neural stem cells, donor1	11275-116H6	500.86	18.15	6.90	0.36	0.73	3.63	8.35
Neural stem cells, donor2	11352-117H2	396.68	46.22	5.78	0.00	3.85	1.93	0.00
Neurons, donor1	11494-119E9	762.39	50.07	5.69	0.00	2.28	3.41	0.00
Neurons, donor2	11574-120E8	363.05	26.42	7.05	1.76	1.98	2.42	1.10
Neurons, donor3	11655-122E8	487.54	19.73	3.29	2.47	2.47	12.33	0.82
Neutrophils, donor1	11233-116C9	2457.36	240.35	3.71	33.41	12.06	22.27	12.99
Neutrophils, donor2	11314-117C9	2933.66	176.83	0.00	14.49	5.80	46.38	31.89
Neutrophils, donor3	11390-118C4	2834.31	208.30	0.61	120.95	9.77	15.88	17.71
Nucleus Pulposus Cell, donor1	11252-116F1	330.68	17.81	8.91	0.59	2.73	0.71	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	472.78	14.00	5.54	0.00	2.93	1.63	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	180.10	16.45	1.20	0.00	1.20	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	397.95	24.64	4.68	1.93	3.17	1.93	1.65
Olfactory epithelial cells, donor2	11934-125I8	569.14	28.95	3.33	2.61	3.18	13.61	3.76
Olfactory epithelial cells, donor3	11935-125I9	397.27	24.97	3.86	0.45	2.61	1.93	0.57
Olfactory epithelial cells, donor4	11936-126A1	411.41	19.28	3.60	0.39	5.45	1.85	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	788.38	72.82	9.63	1.81	2.41	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	246.94	19.36	1.28	0.00	0.21	1.06	0.64
Osteoblast - differentiated, donor2	11353-117H3	274.35	6.86	1.14	0.00	1.14	0.00	4.57
Osteoblast - differentiated, donor3	11425-118G3	296.70	16.76	4.97	1.24	0.62	2.48	2.48
Osteoblast, donor1	11277-116H8	930.67	68.99	10.16	0.78	5.86	2.35	1.56
Osteoblast, donor2	11354-117H4	714.96	13.34	7.73	0.00	1.40	4.92	0.70
Osteoblast, donor3	11426-118G4	804.41	53.85	6.40	0.18	3.02	0.53	1.60
Pancreatic stromal cells, donor1	11249-116E7	389.59	26.79	4.38	0.08	3.45	2.27	3.03
Pericytes, donor1	11491-119E6	293.41	28.48	1.45	0.00	1.45	0.11	0.45
Pericytes, donor2	11571-120E5	181.09	12.68	2.04	0.23	1.13	1.36	0.91
Pericytes, donor3	11652-122E5	536.09	35.60	5.09	0.00	3.26	2.44	0.81
Perineurial Cells, donor1	11499-119F5	285.38	28.93	2.60	0.00	2.49	1.24	0.00
Perineurial Cells, donor2	11579-120F4	378.72	30.46	4.88	2.21	2.85	0.74	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	639.39	46.54	4.46	13.39	1.91	1.91	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	745.36	52.89	4.90	31.83	3.43	5.39	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	568.01	37.40	4.27	11.52	3.24	1.55	0.78
Placental Epithelial Cells, donor1	11278-116H9	996.37	100.69	3.35	0.00	1.91	4.30	3.59
Placental Epithelial Cells, donor2	11355-117H5	1115.54	58.77	3.33	0.00	3.33	4.44	4.44
Placental Epithelial Cells, donor3	11427-118G5	818.49	54.58	3.14	0.00	2.36	3.34	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	306.01	27.85	3.16	0.00	1.27	5.06	2.53
Preadipocyte - breast, donor1	11467-119B9	221.73	13.88	2.44	0.38	0.75	2.44	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	327.88	24.67	5.48	0.65	1.04	1.57	0.39
Preadipocyte - breast, donor2	11328-117E5	272.66	15.76	5.18	0.00	3.15	2.70	1.35
Preadipocyte - omental, donor1	11468-119C1	235.17	12.47	3.41	0.00	1.07	2.13	2.88
Preadipocyte - omental, donor2	11329-117E6	324.73	16.15	6.98	0.00	4.36	2.18	1.75
Preadipocyte - omental, donor3	11403-118D8	323.89	24.93	6.16	0.00	1.00	3.87	1.15
Preadipocyte - perirenal, donor1	11469-119C2	315.95	30.51	0.00	0.00	5.91	3.94	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	660.30	65.11	8.60	0.31	7.06	2.15	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	970.91	64.10	9.39	0.71	4.78	7.61	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	634.65	61.64	7.66	0.51	3.92	5.62	3.07
Preadipocyte - visceral, donor1	11280-116I2	607.51	45.92	7.17	1.02	4.38	4.10	5.22
Preadipocyte - visceral, donor2	11357-117H7	819.12	27.15	5.06	0.92	6.90	8.74	2.76
Preadipocyte - visceral, donor3	11429-118G7	554.32	47.96	2.82	1.25	4.08	3.66	3.76
Prostate Epithelial Cells (polarized), donor1	11253-116F2	352.54	25.64	2.87	0.00	0.00	5.73	6.49
Prostate Epithelial Cells, donor2	11331-117E8	844.44	49.70	3.39	0.00	4.33	14.49	17.74
Prostate Epithelial Cells, donor3	11404-118D9	314.33	25.90	2.20	0.00	2.14	5.14	6.12
Prostate Stromal Cells, donor1	11254-116F3	617.45	30.87	5.47	0.00	3.87	2.85	3.64
Prostate Stromal Cells, donor2	11332-117E9	521.04	23.85	6.10	0.00	5.20	3.23	2.15
Prostate Stromal Cells, donor3	11405-118E1	269.66	23.36	2.71	0.10	5.11	4.28	4.17
Renal Cortical Epithelial Cells, donor1	11516-119H4	852.60	124.09	9.85	0.00	4.38	0.00	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	791.68	62.03	7.42	0.55	4.16	1.66	1.25
Renal Epithelial Cells, donor1	11517-119H5	1179.82	107.53	18.77	0.51	11.16	0.51	1.01
Renal Epithelial Cells, donor2	11597-120H4	1301.00	96.03	22.76	1.42	7.11	2.13	2.85
Renal Epithelial Cells, donor3	11678-122H4	1017.04	65.21	7.94	0.95	4.34	1.59	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	630.47	61.28	2.04	0.00	4.77	0.68	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	579.35	50.94	2.83	0.40	4.99	2.83	2.29
Renal Glomerular Endothelial Cells, donor3	11675-122H1	1102.95	67.71	8.21	1.11	2.22	4.66	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	923.64	88.50	6.65	0.67	1.33	2.66	2.00
Renal Mesangial Cells, donor1	11518-119H6	906.98	87.38	9.46	0.22	6.16	0.88	1.10
Renal Mesangial Cells, donor2	11598-120H5	1442.69	108.47	10.66	0.63	7.52	1.88	3.13
Renal Mesangial Cells, donor3	11679-122H5	1109.09	95.71	14.70	0.83	6.94	3.33	4.72
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	477.52	48.05	9.13	0.00	6.44	0.81	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	398.50	37.53	7.17	0.00	1.69	0.84	3.80
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1171.74	78.10	15.23	0.39	5.79	4.05	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	262.91	22.56	5.19	0.26	3.63	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	654.61	67.65	5.12	0.28	4.26	2.56	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	551.61	51.46	7.20	0.00	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	564.79	21.33	6.02	1.76	2.26	0.75	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	458.37	17.64	6.68	0.67	1.60	1.47	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	315.37	10.72	3.57	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	358.84	18.16	1.65	0.00	0.00	3.30	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	305.11	6.38	4.64	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	472.25	17.81	1.95	0.13	0.52	0.26	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	579.65	18.37	12.21	0.00	1.69	0.99	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	665.00	22.31	16.40	0.11	2.12	1.00	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	651.72	24.93	5.71	0.12	1.36	2.23	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	707.78	20.40	12.59	0.12	1.63	1.98	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	768.51	23.11	11.56	0.23	0.46	2.54	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	543.94	22.45	3.56	0.27	0.82	0.96	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	603.58	18.46	13.92	0.00	0.61	1.97	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	509.80	23.83	12.54	0.00	2.15	1.43	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	613.56	22.38	5.31	0.14	1.29	0.86	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	712.78	21.03	12.56	0.00	0.86	1.93	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	661.82	24.56	11.73	0.00	0.66	2.43	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	530.90	21.22	3.06	0.19	0.38	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	524.69	20.22	10.81	0.09	0.93	1.30	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	718.18	16.91	14.66	0.19	0.75	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	449.35	16.59	2.92	0.13	1.46	1.46	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	576.36	20.25	11.97	0.10	1.07	1.95	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	700.25	17.38	12.79	0.19	2.48	2.10	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	535.89	16.77	4.38	0.00	0.96	1.17	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	680.30	12.61	12.33	0.28	1.12	5.61	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	678.64	17.26	12.99	0.34	1.54	2.39	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	528.58	18.23	4.56	0.00	0.55	1.28	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	649.95	21.09	14.10	0.12	1.10	3.19	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	704.78	29.28	14.78	0.27	1.21	2.01	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	834.99	29.48	3.07	0.00	2.12	1.89	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	681.95	17.86	11.90	0.00	0.79	2.78	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	749.94	21.28	14.26	0.23	1.87	1.40	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	626.83	32.14	5.60	0.00	1.45	1.24	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	776.00	20.13	12.17	0.00	0.66	7.08	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	599.08	20.47	13.37	0.00	0.63	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	637.66	27.86	5.79	0.00	1.62	1.21	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	498.45	15.16	9.37	0.00	1.02	1.19	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	594.96	18.51	13.69	0.19	1.54	2.70	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	725.40	26.48	5.50	0.52	0.34	1.03	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	501.08	14.40	12.21	0.14	0.82	1.92	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	640.26	17.07	14.78	0.66	1.64	3.78	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	573.67	19.09	2.90	0.17	0.51	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	634.44	26.04	13.17	0.30	1.33	0.89	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	604.00	23.99	11.99	0.00	1.33	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	331.56	11.48	4.56	0.28	0.69	0.41	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	548.35	20.00	12.62	0.24	2.62	1.43	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	580.24	23.38	15.12	0.20	1.61	1.81	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	529.64	22.04	5.37	0.00	2.26	2.45	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	543.26	18.52	16.07	0.70	2.10	3.84	5.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	370.21	16.02	9.97	0.30	0.91	1.51	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	598.96	20.93	3.55	0.49	0.86	2.08	4.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	316.72	11.79	7.42	0.29	0.73	1.31	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	547.59	19.47	8.52	0.00	1.22	3.04	6.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	593.76	19.29	3.62	0.00	0.60	1.51	4.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	498.97	19.00	9.27	0.45	0.68	5.43	10.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	538.27	24.86	8.69	0.30	3.00	2.40	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	315.38	12.87	1.77	0.59	0.12	2.60	6.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	439.91	17.50	8.11	0.85	1.07	2.77	8.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	454.94	19.23	9.62	0.60	1.80	1.80	4.21
Schwann Cells, donor1	11498-119F4	803.06	73.54	6.58	0.38	4.89	3.01	1.69
Schwann Cells, donor2	11578-120F3	714.51	51.04	17.01	0.00	6.80	3.40	3.40
Schwann Cells, donor3	11659-122F3	874.57	59.15	9.42	0.66	3.51	3.51	0.22
Sebocyte, donor1	11220-116B5	1142.65	117.22	6.57	0.00	2.74	1.10	1.10
Sebocyte, donor2	11301-117B5	844.66	51.93	7.35	0.00	2.76	6.89	1.38
Sebocyte, donor3	11378-118B1	603.29	41.43	4.33	0.00	3.09	2.47	2.47
Sertoli Cells, donor1	11255-116F4	733.87	61.29	6.63	0.00	6.63	6.63	6.63
Sertoli Cells, donor2	11333-117F1	1124.10	19.77	8.47	0.00	2.82	19.77	19.77
Skeletal Muscle Cells, donor1	11281-116I3	333.26	38.09	3.17	0.44	2.29	2.73	3.43
Skeletal Muscle Cells, donor2	11358-117H8	113.49	12.29	0.72	0.00	0.72	1.45	2.17
Skeletal Muscle Cells, donor3	11430-118G8	1008.26	69.39	4.18	0.84	5.85	3.34	3.34
Skeletal Muscle Cells, donor4	11451-119A2	452.74	31.10	2.20	0.47	1.73	1.89	1.26
Skeletal Muscle Cells, donor5	11455-119A6	460.95	29.43	3.12	0.15	1.64	1.93	1.19
Skeletal Muscle Cells, donor6	11459-119B1	462.17	42.78	3.54	0.15	2.31	1.85	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	383.94	30.24	6.80	0.00	4.28	2.27	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	413.08	24.83	6.14	0.29	5.14	1.28	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	565.00	34.03	7.84	0.40	2.38	2.68	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	239.53	17.95	2.36	0.25	1.10	1.69	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	591.31	53.56	3.62	0.00	6.51	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	562.78	27.38	3.72	0.14	3.99	2.61	1.79
Skin - palm, donor1	10286-104F7	1095.93	34.92	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	998.43	68.04	2.88	0.00	2.16	11.24	8.36
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	805.62	33.53	0.00	3.27	1.64	3.27	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	981.11	66.47	5.06	0.52	4.15	7.40	5.45
Small Airway Epithelial Cells, donor1	11256-116F5	947.48	55.60	5.28	0.00	4.73	10.84	12.93
Small Airway Epithelial Cells, donor2	11334-117F2	629.02	42.76	3.38	0.00	3.38	5.49	3.94
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	530.52	33.83	2.54	5.29	4.23	2.11	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	421.67	31.18	3.45	0.07	1.50	2.32	2.85
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	602.36	33.94	1.23	0.00	4.63	3.39	4.94
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	246.56	14.67	1.33	0.00	0.67	1.11	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	476.14	27.63	7.64	0.00	8.23	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	546.51	26.30	4.64	0.44	3.98	1.10	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	973.42	86.63	9.06	0.00	5.51	3.54	3.15
Smooth Muscle Cells - Aortic, donor3	11432-118H1	556.25	23.18	3.86	0.00	12.36	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	236.18	15.01	6.00	1.00	3.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	831.47	80.91	7.45	0.40	4.52	1.60	3.19
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	475.01	38.35	4.43	0.22	2.88	4.88	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	898.39	80.92	3.46	0.51	5.76	2.30	3.84
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	186.56	11.72	2.93	0.00	0.98	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	302.71	20.08	4.43	0.30	1.48	1.77	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	359.04	24.91	5.13	0.00	2.85	1.42	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	731.71	62.96	7.97	0.16	4.07	1.30	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	761.08	46.27	5.78	0.30	0.91	1.52	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	344.75	36.87	2.53	0.00	8.59	0.25	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	471.29	48.97	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1070.98	88.69	2.86	0.00	5.25	4.77	5.25
Smooth Muscle Cells - Colonic, donor1	11239-116D6	313.97	23.89	3.24	0.00	2.80	2.36	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	338.36	18.08	4.30	0.00	2.15	1.51	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	381.63	25.61	5.77	0.31	2.31	2.52	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	891.57	74.25	7.73	0.00	6.81	1.39	2.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	933.44	65.75	7.55	1.08	6.47	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	697.83	45.13	4.18	0.00	10.16	2.09	2.09
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	678.02	65.89	4.44	0.00	4.10	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	615.43	35.65	4.32	0.63	4.48	1.02	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	556.85	41.26	4.23	0.20	3.82	8.55	14.09
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	641.24	49.15	2.50	0.00	2.28	2.50	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1082.03	91.78	0.00	0.00	8.45	1.81	4.83
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	348.38	29.94	5.30	0.53	3.18	2.12	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	259.93	28.50	1.33	0.00	4.53	1.07	2.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	337.09	26.17	4.76	0.00	3.63	4.38	3.51
Smooth Muscle Cells - Prostate, donor3	11465-119B7	225.76	15.98	4.82	0.00	2.79	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	729.29	62.57	8.74	0.45	5.13	2.56	2.41
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	565.63	36.76	3.75	0.00	8.25	2.25	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	457.44	41.35	2.58	0.00	3.88	1.29	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	399.03	37.67	5.58	0.00	5.12	1.86	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1061.77	70.18	6.06	0.00	3.03	4.54	4.54
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	639.01	63.62	3.13	0.00	5.64	2.19	6.89
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	286.44	28.02	2.65	0.00	5.31	0.88	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	439.19	42.40	4.75	0.08	4.33	0.58	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	547.51	37.84	8.41	0.47	3.74	1.87	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1068.02	107.94	8.78	0.00	5.18	3.17	5.18
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	1357.89	111.67	9.43	0.76	4.59	3.06	4.33
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1074.80	107.18	2.07	0.19	6.96	3.01	3.01
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	397.29	37.59	3.21	0.42	2.52	0.70	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	599.50	68.12	4.27	0.08	2.60	1.51	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	484.75	48.57	5.24	0.48	4.29	1.90	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	1011.92	112.54	8.32	0.24	6.85	3.67	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	222.94	25.41	0.88	0.00	1.55	1.77	3.76
Smooth Muscle Cells - Uterine, donor3	11466-119B8	340.85	29.84	4.68	0.59	10.24	1.76	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	568.31	39.84	2.33	0.58	1.17	3.30	4.08
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	275.82	16.93	2.12	0.00	0.79	1.32	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	398.73	25.66	1.12	0.00	1.12	7.81	8.18
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	445.58	32.70	2.87	0.36	3.23	1.08	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	308.88	27.25	2.56	0.28	1.42	1.99	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	788.52	26.78	7.09	0.39	1.97	5.12	4.33
Smooth muscle cells - airway, control, donor1	11966-126D4	292.04	25.65	2.29	0.00	2.03	3.30	2.79
Smooth muscle cells - airway, control, donor2	11967-126D5	301.89	28.35	1.60	0.40	1.60	3.99	4.79
Smooth muscle cells - airway, control, donor3	11968-126D6	379.13	28.42	0.84	0.42	0.84	7.52	7.11
Smooth muscle cells - airway, control, donor4	11969-126D7	480.82	32.09	2.75	0.92	2.29	2.29	2.29
Synoviocyte, donor1	11291-117A4	709.98	45.45	5.72	0.34	1.85	5.89	4.88
Synoviocyte, donor2	11368-117I9	371.46	35.20	2.35	1.34	4.69	3.02	3.52
Synoviocyte, donor3	11440-118H9	156.83	17.43	0.67	0.00	1.34	3.57	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	731.81	70.39	7.15	0.36	7.50	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	299.29	35.68	1.98	0.00	7.93	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	556.64	49.09	8.10	0.23	6.71	1.39	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	669.46	49.68	5.30	0.07	2.51	1.36	2.15
Tracheal Epithelial Cells, donor2	11369-118A1	828.79	54.51	6.96	0.39	5.03	1.55	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	739.88	68.72	1.72	0.00	0.57	1.15	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	459.25	18.21	5.17	0.86	0.49	0.98	1.11
Urethra, donor2	10319-105A4	249.98	5.40	0.00	0.00	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	911.75	103.87	3.72	0.00	6.38	3.98	1.33
Urothelial Cells, donor2	11600-120H7	804.33	77.71	3.20	0.00	4.01	5.21	2.00
Urothelial Cells, donor3	11681-122H7	895.27	92.60	3.67	0.23	3.21	5.27	1.38
Urothelial cells, donor0	11216-116B1	662.00	83.14	3.57	0.00	3.12	1.34	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	5068.20	306.09	3.56	8.01	13.35	8.01	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	5133.73	337.39	5.72	10.01	11.44	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	3581.41	134.85	13.01	10.95	6.16	12.32	3.42
Whole blood (ribopure), donor090325, donation1	12176-128I7	2059.14	116.73	6.54	4.48	2.75	5.51	3.79
Whole blood (ribopure), donor090325, donation2	12177-128I8	2482.15	95.87	7.55	6.39	4.07	5.81	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	3884.87	282.18	5.21	11.45	19.78	1.04	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	3732.66	251.48	3.67	6.42	8.26	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	4119.00	163.41	10.95	7.30	5.48	21.91	6.39
Wilms' tumor cell line:G-401	10809-111A8	24.43	2.84	1.36	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	7.92	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	386.30	22.35	9.78	0.00	1.12	1.68	1.12
achilles tendon, donor2	10292-104G4	570.36	8.27	2.07	18.60	0.00	4.13	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	370.20	56.86	7.14	3.06	0.25	3.57	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	298.81	34.36	12.07	1.16	0.00	0.46	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	413.34	42.85	9.38	1.78	0.12	0.71	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	277.01	16.05	16.60	0.00	0.00	0.82	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1198.26	41.60	13.21	0.28	0.00	3.94	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	941.30	50.54	19.24	2.33	0.21	4.23	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1115.52	37.57	5.44	0.54	0.27	1.91	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	278.92	9.69	9.69	0.00	0.00	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	808.96	37.16	15.11	3.27	0.82	2.45	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	374.71	21.36	15.53	0.00	0.00	0.78	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	840.14	31.65	32.38	0.18	0.00	1.47	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	417.36	19.50	11.70	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1598.55	81.80	9.99	0.00	0.23	3.25	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	682.72	25.63	16.31	0.26	0.00	1.04	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	554.97	20.16	22.21	0.00	0.00	2.05	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	441.06	22.77	10.69	0.46	0.93	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	831.96	21.39	11.52	0.00	0.00	2.47	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	349.00	10.74	11.05	0.00	0.61	1.84	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	621.29	29.87	25.18	0.00	2.56	2.99	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	733.67	47.31	27.60	0.00	3.64	1.21	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	762.80	32.98	31.53	4.33	2.65	1.20	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	752.86	42.54	15.59	0.00	0.22	1.34	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1405.90	72.38	5.67	0.67	2.67	1.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	334.48	5.57	9.29	0.00	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1429.43	44.45	11.68	0.00	0.75	3.39	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	998.74	53.64	17.88	0.00	0.87	2.18	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	328.03	20.62	5.62	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	394.46	25.20	9.42	0.00	0.47	0.94	1.65
adipose tissue, adult, pool1	10010-101C1	393.69	14.12	3.72	0.16	1.86	0.47	1.09
adipose, donor1	10184-103D4	32.84	1.76	1.17	0.00	0.00	2.35	3.52
adipose, donor2	10185-103D5	44.20	3.65	3.24	0.41	0.41	6.89	6.49
adipose, donor3	10186-103D6	99.93	6.53	3.27	0.82	0.00	5.45	5.17
adipose, donor4	10187-103D7	78.01	7.80	2.60	1.73	0.00	1.73	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.47	0.47	7.58	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	50.93	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	823.12	109.26	10.94	0.80	5.34	3.07	2.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	505.58	39.30	6.79	0.00	5.00	5.00	2.14
amniotic membrane cells, donor1	12235-129G3	1061.87	76.28	3.01	3.94	1.39	7.19	1.85
amniotic membrane cells, donor2	12236-129G4	618.05	38.21	2.37	4.40	1.35	3.04	0.00
amniotic membrane cells, donor3	12237-129G5	1038.47	51.56	2.65	0.88	2.65	3.83	2.36
amygdala - adult, donor10196	10167-103B5	53.36	0.00	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	133.83	5.68	3.85	0.00	0.41	0.41	0.41
amygdala, newborn, donor10223	10360-105E9	148.47	6.46	7.10	2.90	0.00	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	230.21	16.68	2.80	0.25	1.53	0.38	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	675.33	76.78	14.34	0.22	1.99	5.52	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	178.71	35.41	6.68	1.34	0.67	0.67	0.00
aorta, adult, pool1	10052-101G7	327.15	19.42	4.71	2.16	3.33	2.35	1.57
appendix, adult	10189-103D9	386.95	26.00	1.94	0.78	0.00	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1186.23	41.96	17.88	1.38	0.69	6.19	3.78
artery, adult	10190-103E1	270.38	13.59	1.36	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	677.11	50.27	11.88	0.58	2.03	2.32	0.72
b cell line:RPMI1788	10427-106D4	370.56	52.49	8.33	2.83	1.49	0.74	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	573.21	63.54	3.05	0.55	3.88	5.83	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	410.52	39.30	7.54	0.20	3.08	1.19	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	309.65	25.61	2.68	0.33	0.33	1.67	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	336.10	21.25	13.98	4.47	0.56	3.36	1.12
bladder, adult, pool1	10011-101C2	279.21	13.04	2.61	0.22	1.52	0.65	0.76
blood, adult, pool1	10053-101G8	1286.70	55.37	13.29	0.00	0.00	6.64	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	631.13	46.24	2.57	0.00	3.43	2.57	0.00
bone marrow, adult	10192-103E3	307.72	7.42	3.37	0.00	0.67	2.02	2.70
brain, adult, donor1	10084-102B3	38.95	0.00	1.03	0.00	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	69.15	3.67	1.00	0.00	0.33	0.11	0.11
brain, fetal, pool1	10085-102B4	77.47	10.69	2.67	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	352.17	11.23	2.97	0.66	0.33	1.65	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	218.44	9.49	4.37	0.00	0.37	0.00	0.12
breast, adult, donor1	10080-102A8	251.91	7.58	2.53	0.00	3.16	1.89	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	673.68	32.27	12.70	0.13	0.76	2.54	1.52
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1470.03	54.11	17.01	13.30	2.78	8.97	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	533.88	29.93	14.04	0.00	2.30	3.68	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	686.80	37.28	7.50	0.24	0.97	3.15	1.45
carcinoid cell line:NCI-H1770	10703-109H1	237.43	11.28	14.58	0.00	0.00	0.94	1.88
carcinoid cell line:NCI-H727	10735-110B6	229.04	22.09	2.63	0.44	0.66	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	127.08	4.44	5.07	0.00	0.00	1.58	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	126.17	6.92	6.92	0.00	0.27	0.53	0.80
caudate nucleus - adult, donor10196	10177-103C6	89.80	3.45	1.15	0.00	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	102.74	3.85	1.17	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	38.97	0.76	0.76	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	221.94	10.25	2.93	0.37	0.37	1.10	1.10
cerebellum - adult, donor10196	10173-103C2	37.87	0.00	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	73.66	1.49	0.64	0.00	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	28.29	1.03	0.34	0.00	0.00	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	74.73	2.49	0.83	0.00	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	93.80	2.27	2.52	0.00	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	157.14	5.85	1.46	3.65	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	244.57	19.41	5.46	0.14	1.87	1.01	0.43
cervical cancer cell line:ME-180	10553-107I4	581.33	45.74	1.49	0.33	0.33	1.33	1.82
cervix, adult, pool1	10013-101C4	315.08	13.86	3.57	0.63	2.83	1.36	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	423.73	29.96	4.46	0.00	2.79	3.20	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	175.04	5.23	5.23	0.00	6.53	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	416.45	25.85	6.59	0.00	1.74	4.23	6.21
choriocarcinoma cell line:SCH	10785-110H2	466.85	33.14	3.57	0.00	2.09	2.46	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	242.40	14.71	8.30	0.24	0.24	1.66	1.42
chorionic membrane cells, donor1	12238-129G6	1310.34	79.21	9.12	4.56	3.42	12.54	3.99
chorionic membrane cells, donor2	12239-129G7	786.00	55.08	2.98	0.10	4.37	6.76	7.06
chorionic membrane cells, donor3	12240-129G8	2133.65	102.75	9.89	2.75	8.24	29.12	9.89
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	503.89	52.51	7.07	1.01	0.00	2.02	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1236.73	67.62	15.56	3.84	1.73	5.96	3.46
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	734.08	40.34	17.53	0.42	0.63	4.86	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	647.39	52.90	5.91	0.26	1.80	1.03	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	673.87	54.66	8.47	0.48	1.94	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	675.58	53.96	8.55	0.61	1.63	1.43	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	487.32	28.86	6.18	0.00	0.00	1.47	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	864.76	41.96	9.64	0.52	0.52	1.04	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	366.87	21.03	22.17	0.23	6.17	4.57	2.74
clear cell carcinoma cell line:TEN	10636-108I6	500.91	31.40	6.25	2.26	5.73	3.30	1.39
colon carcinoma cell line:CACO-2	10513-107D9	758.34	48.87	6.77	0.00	0.37	0.92	1.10
colon carcinoma cell line:COLO-320	10420-106C6	215.51	11.40	18.24	0.00	0.00	0.76	0.00
colon, adult, donor1	10082-102B1	320.12	22.61	7.14	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	267.67	17.86	3.88	0.24	0.94	1.18	0.94
colon, fetal, donor1	10070-101I7	239.78	14.83	3.71	0.00	1.85	4.33	3.71
common myeloid progenitor CMP, donor1	12130-128D6	224.59	9.17	9.17	41.25	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	776.14	50.07	25.04	50.07	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	292.35	67.99	1.70	1.70	0.85	2.12	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	526.45	99.61	3.17	0.60	1.06	3.47	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	562.92	104.91	3.24	0.14	1.41	1.83	0.85
corpus callosum, adult, pool1	10042-101F6	117.97	6.85	2.10	0.44	1.88	0.00	0.00
cruciate ligament, donor2	10295-104G7	527.62	21.88	6.48	1.62	1.62	2.43	3.24
diaphragm, fetal, donor1	10069-101I6	201.44	6.42	2.41	0.80	3.21	4.01	0.00
diencephalon, adult	10193-103E4	63.60	4.80	1.44	0.24	0.48	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	607.78	64.06	8.95	0.69	0.00	5.28	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	616.48	46.42	6.41	0.26	3.85	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	59.22	3.13	2.65	0.00	0.48	0.24	0.00
ductus deferens, adult	10196-103E7	310.96	11.96	3.99	0.00	0.00	1.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	285.17	18.72	7.20	0.00	0.00	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	576.75	33.10	2.94	0.00	0.74	4.41	0.00
dura mater, adult, donor1	10041-101F5	374.95	24.12	5.29	1.49	1.40	0.58	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	369.31	45.75	5.33	1.11	1.33	4.00	8.88
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	920.23	49.44	9.60	0.00	1.43	4.87	5.88
embryonic pancreas cell line:1B2C6	10604-108F1	160.94	3.70	3.08	0.62	0.62	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	279.10	11.50	5.15	0.30	1.82	2.42	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	205.32	6.17	2.16	0.00	0.62	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	174.69	7.88	2.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	294.30	27.82	4.02	0.67	0.00	1.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	277.65	19.94	11.60	0.18	4.53	3.26	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	696.80	34.41	5.95	0.16	0.48	4.99	3.06
epidermoid carcinoma cell line:A431	10426-106D3	516.22	44.46	1.89	1.56	1.33	0.56	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	824.78	68.63	9.35	0.22	2.09	1.32	0.55
epididymis, adult	10197-103E8	272.52	15.70	2.72	0.00	1.26	1.47	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	189.12	13.84	6.74	0.53	2.66	0.89	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	182.07	8.65	1.18	0.00	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	446.88	22.28	7.34	0.00	2.75	1.44	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	368.48	16.83	7.09	0.00	0.69	0.89	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	465.71	25.43	9.41	0.11	1.57	1.79	1.12
esophagus, adult, pool1	10015-101C6	458.80	29.31	2.97	0.11	1.06	1.38	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1.88	0.13	0.63	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	330.80	14.49	2.41	0.00	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	263.03	4.21	2.10	4.21	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	142.87	1.49	2.98	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	300.38	11.46	1.15	1.15	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	427.02	23.32	1.46	4.37	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	239.23	16.27	5.85	0.00	0.76	2.03	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	542.65	53.47	8.21	1.03	2.69	2.56	2.05
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	418.10	31.10	7.60	0.71	3.32	1.66	1.66
frontal lobe, adult, pool1	10040-101F4	42.69	2.25	0.84	0.09	0.00	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	635.63	7.21	4.80	1.20	1.80	6.61	2.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	592.87	59.16	6.40	0.46	1.10	1.01	0.73
gall bladder, adult	10198-103E9	335.59	14.49	3.86	0.00	1.93	2.41	1.45
gamma delta positive T cells, donor1	11937-126A2	738.71	39.73	8.05	4.29	1.07	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	833.26	51.92	6.72	2.24	2.99	2.24	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	1931.36	80.26	8.45	2.75	1.69	13.31	8.45
gastric adenocarcinoma cell line:MKN45	10612-108F9	223.40	9.67	3.29	0.00	0.00	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	20.33	0.49	5.08	0.00	0.16	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	97.93	4.58	10.98	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	552.18	14.85	5.03	4.11	1.83	2.51	1.60
giant cell carcinoma cell line:LU65	10487-107B1	282.26	22.37	2.29	0.00	0.69	1.15	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	177.61	9.80	6.86	0.00	1.96	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	567.68	33.92	4.99	0.00	1.75	1.75	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	843.05	71.25	11.82	0.42	9.18	1.58	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	611.47	55.47	11.09	0.28	9.13	1.26	0.84
glioblastoma cell line:T98G	10485-107A8	473.50	31.13	7.62	0.33	2.43	0.88	0.44
glioma cell line:GI-1	10413-106B8	335.05	27.82	9.08	2.05	2.05	1.17	3.81
globus pallidus - adult, donor10196	10175-103C4	94.76	2.92	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	228.47	7.57	3.17	0.00	0.00	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	98.58	5.48	5.48	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	294.17	12.79	2.13	0.53	0.00	3.20	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	349.94	31.81	12.24	12.24	2.45	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	1092.84	0.00	21.86	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	951.24	52.27	31.36	10.45	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	1034.22	43.52	4.80	0.64	1.28	3.52	2.88
hIPS +CCl2, biol_rep1	14383-156B9	146.00	22.04	2.30	0.00	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	173.30	22.86	0.46	0.46	0.00	0.00	1.37
hIPS +CCl2, biol_rep3	14385-156C2	157.80	20.61	0.64	0.00	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	44.56	33.06	1.44	0.00	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	90.53	20.58	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	88.28	4.41	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	593.94	62.35	8.91	2.01	1.15	2.87	0.57
heart - mitral valve, adult	10205-103F7	674.17	25.41	2.39	0.00	1.79	2.69	1.20
heart - pulmonic valve, adult	10206-103F8	254.42	13.34	1.05	0.26	1.05	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	725.23	28.31	1.67	0.00	1.67	0.83	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	358.94	20.81	4.90	0.00	0.61	5.10	1.84
heart, adult, diseased, donor1	10051-101G6	308.30	17.46	1.28	0.00	0.85	0.43	1.28
heart, adult, pool1	10016-101C7	238.26	15.18	0.23	0.23	0.46	0.92	0.23
heart, fetal, pool1	10046-101G1	279.49	12.94	2.46	0.21	1.03	0.31	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	335.98	35.79	2.47	0.93	2.78	2.78	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	76.11	3.57	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	36.57	2.21	2.43	0.00	0.00	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	35.08	2.43	2.06	0.49	0.12	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	40.62	1.01	1.72	0.10	0.00	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	405.16	27.92	1.67	1.45	0.11	2.11	1.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	491.75	57.29	8.74	2.11	0.50	1.81	0.90
hippocampus - adult, donor10196	10169-103B7	69.08	0.95	0.00	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	126.95	4.08	1.43	0.00	0.00	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	36.35	5.48	0.50	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	164.25	5.99	1.76	1.41	0.00	1.41	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	167.23	18.31	4.27	1.83	0.00	4.27	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	149.62	16.69	4.71	1.96	0.20	1.77	2.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	147.26	23.36	1.27	1.78	0.00	1.02	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	52.44	2.82	3.95	0.00	0.00	2.26	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	52.68	4.39	1.55	0.26	0.00	5.42	6.20
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	65.29	6.83	2.28	0.00	0.00	1.90	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	52.55	8.17	2.34	0.88	0.29	3.21	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.95	4.31	3.45	0.00	0.22	3.02	4.74
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	77.58	7.09	1.25	0.42	0.00	2.92	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	194.17	13.97	4.97	0.00	0.71	2.60	3.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	182.09	18.00	6.43	0.32	0.48	3.54	9.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	113.79	13.47	0.00	0.00	0.00	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	74.02	7.98	1.41	0.78	0.00	1.56	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	76.64	9.83	0.98	0.98	0.00	3.93	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	96.00	6.98	3.49	3.49	0.00	6.11	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	44.48	1.91	2.67	0.00	0.00	1.91	3.82
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.48	2.18	3.92	0.44	0.00	2.18	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.49	3.00	2.00	0.00	0.00	3.00	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	80.82	3.77	4.33	0.38	0.38	3.39	3.77
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	85.03	5.00	2.73	0.45	0.91	4.09	5.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	75.18	5.95	4.70	0.31	0.31	3.13	6.89
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	306.35	17.31	4.57	0.82	0.49	7.02	11.76
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	337.63	20.61	6.10	0.00	1.74	6.10	12.77
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	246.91	17.94	5.08	0.90	0.60	6.88	11.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	156.85	14.96	2.03	1.66	0.00	3.69	4.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	133.80	15.41	3.71	1.14	1.14	1.43	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	182.92	24.09	0.82	0.41	0.00	6.12	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	92.25	4.58	2.46	0.35	0.00	5.28	9.15
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	70.95	6.65	2.85	0.32	0.00	3.80	7.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	108.04	10.29	3.33	0.00	0.30	3.03	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	88.43	8.27	2.59	0.00	0.00	1.55	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	83.68	5.98	5.31	0.66	0.66	2.66	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	101.84	8.98	4.10	0.26	0.26	1.28	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	398.04	30.68	7.16	0.26	0.77	9.46	13.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	201.42	18.17	4.54	0.00	0.00	5.30	9.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	373.02	31.59	7.73	1.01	1.68	9.07	21.84
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	115.44	15.46	1.21	1.45	0.00	3.38	5.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	126.12	17.38	2.67	1.34	0.00	4.46	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	118.05	19.51	1.95	0.49	0.00	6.34	7.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	58.37	6.11	1.22	0.00	0.00	1.22	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	87.84	9.76	9.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	76.12	6.29	3.64	0.00	0.33	2.32	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	88.12	5.47	4.38	0.55	0.00	2.74	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	72.38	5.43	5.43	0.36	0.00	0.72	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	69.04	6.76	3.91	0.36	0.71	1.07	3.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	334.15	20.29	2.39	2.39	0.00	2.39	16.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	346.96	31.82	6.36	0.14	0.68	3.11	12.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	283.13	25.05	5.66	0.00	0.27	5.12	11.58
immature langerhans cells, donor1	11904-125F5	637.81	43.59	5.57	1.94	0.73	1.70	1.45
immature langerhans cells, donor2	11905-125F6	1092.35	46.74	11.09	7.92	3.96	5.54	2.38
insula, adult, pool1	10039-101F3	57.92	3.22	2.65	0.00	0.00	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	855.14	48.77	3.25	1.30	0.98	8.45	10.08
kidney, adult, pool1	10017-101C8	365.97	17.22	5.61	0.00	1.20	0.80	0.70
kidney, fetal, pool1	10045-101F9	216.73	11.46	4.46	0.64	0.78	0.14	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	187.75	17.47	3.27	0.28	0.99	0.57	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	108.38	14.79	4.15	0.00	0.00	1.38	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	333.24	11.19	2.39	0.73	1.65	0.00	0.00
left atrium, adult, donor1	10079-102A7	133.49	16.35	1.63	0.54	0.00	1.09	1.09
left ventricle, adult, donor1	10078-102A6	290.25	17.19	1.52	0.00	0.51	0.51	3.03
leiomyoblastoma cell line:G-402	10721-110A1	1.64	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	336.62	21.91	2.87	0.00	5.75	6.83	2.87
leiomyoma cell line:15242A	10570-108B3	470.11	37.50	4.89	0.00	8.70	3.26	2.72
leiomyoma cell line:15425	10571-108B4	546.82	35.45	5.34	0.00	6.80	7.53	4.37
leiomyosarcoma cell line:Hs 5.T	10722-110A2	298.42	0.00	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	326.21	20.91	5.23	1.05	0.00	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	869.26	45.81	9.80	2.01	0.71	1.89	1.30
liposarcoma cell line:KMLS-1	10782-110G8	167.93	13.28	4.69	0.16	0.00	1.56	0.47
liposarcoma cell line:SW 872	10726-110A6	652.81	48.61	5.97	1.58	3.90	2.68	0.85
liver, adult, pool1	10018-101C9	727.82	36.63	4.86	0.49	6.48	2.59	3.08
liver, fetal, pool1	10086-102B5	107.24	2.82	2.82	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	119.58	2.77	2.19	0.29	0.58	0.44	0.44
locus coeruleus, adult, donor10252	10165-103B3	166.10	9.04	1.85	0.92	0.00	1.29	1.11
locus coeruleus, adult, donor10258	10375-105G6	89.16	4.80	1.97	0.00	1.13	1.41	0.56
locus coeruleus, newborn, donor10223	10362-105F2	256.58	7.99	2.10	0.42	0.42	3.36	3.36
lung adenocarcinoma cell line:A549	10499-107C4	196.94	7.61	9.00	0.14	1.25	0.55	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	533.60	34.47	9.65	0.69	2.07	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	395.45	37.70	5.80	1.58	2.64	0.92	0.79
lung, adult, pool1	10019-101D1	646.75	32.72	4.96	0.59	2.48	1.77	2.13
lung, fetal, donor1	10068-101I5	970.67	29.11	1.14	1.71	2.28	1.71	2.57
lung, right lower lobe, adult, donor1	10075-102A3	481.59	27.95	3.21	1.37	0.92	15.12	8.71
lymph node, adult, donor1	10077-102A5	260.35	18.93	4.73	0.47	0.47	4.73	1.89
lymphangiectasia cell line:DS-1	10727-110A7	753.97	106.96	12.05	0.88	0.22	5.92	3.29
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	337.32	59.62	5.28	0.15	0.15	1.36	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	769.64	32.28	1.70	0.00	0.85	1.70	0.85
mature adipocyte, donor1	12231-129F8	115.44	9.32	1.78	1.78	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	174.53	13.90	2.70	1.04	2.91	0.00	0.21
mature adipocyte, donor3	12233-129G1	162.63	12.09	1.42	1.42	1.42	0.24	0.24
mature adipocyte, donor4	12234-129G2	134.24	10.00	2.90	1.05	0.26	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	27.16	3.57	0.71	0.00	1.43	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	34.97	2.26	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	101.70	3.68	0.92	0.00	0.00	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	24.46	1.59	0.32	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	139.89	5.12	4.26	1.28	0.00	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	53.16	1.01	1.01	0.00	0.00	1.86	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	117.57	2.12	0.85	0.00	0.21	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	3.85	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	141.42	8.61	3.95	2.87	0.72	1.44	1.79
medulla oblongata - adult, donor10196	10174-103C3	124.60	1.95	1.30	0.00	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	160.69	4.18	2.32	0.00	0.46	0.77	0.15
medulla oblongata, adult, pool1	10038-101F2	162.52	10.20	3.43	0.24	0.65	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	278.09	6.94	4.86	0.69	0.69	1.39	2.78
medulloblastoma cell line:D283 Med	10838-111E1	65.98	13.95	1.55	0.44	0.00	0.44	0.00
medulloblastoma cell line:ONS-76	10759-110E3	1041.27	86.69	14.43	1.47	2.20	2.57	0.86
melanoma cell line:COLO 679	10514-107E1	268.23	18.11	7.76	0.57	0.72	1.72	2.01
melanoma cell line:G-361	10465-106H6	142.79	9.50	5.70	0.00	0.00	4.89	6.24
meningioma cell line:HKBMM	10691-109F7	578.71	52.28	2.17	0.54	0.18	4.52	2.71
merkel cell carcinoma cell line:MKL-1	10843-111E6	675.85	43.18	10.57	0.00	0.00	5.29	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	838.07	45.36	13.74	4.41	0.52	4.67	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	715.92	68.43	6.75	2.15	4.14	3.07	1.69
mesenchymal precursor cell - adipose, donor2	11748-123G2	298.67	32.36	1.64	2.54	3.09	1.45	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	602.93	40.17	0.83	4.56	2.90	2.07	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	269.29	24.58	1.69	0.00	4.50	1.83	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	177.36	16.18	1.54	1.35	1.93	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	284.57	25.68	3.47	0.69	4.86	3.47	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	173.87	20.77	2.57	1.03	4.29	1.54	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	337.92	22.54	2.53	1.50	4.03	1.04	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	652.04	52.52	4.38	1.59	5.17	2.79	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	754.33	57.53	6.35	1.49	4.46	2.57	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	717.29	54.49	4.13	1.99	5.98	1.85	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	464.06	41.17	5.60	0.33	3.62	1.65	2.63
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	811.83	82.19	3.04	4.57	4.43	2.77	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	838.85	50.97	4.19	3.14	6.98	3.49	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	678.24	60.23	2.25	0.82	5.51	1.63	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	486.70	40.26	4.31	3.95	2.52	2.52	3.59
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	1352.09	129.52	3.41	2.59	4.14	4.14	3.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	877.77	64.98	5.02	1.14	2.96	5.02	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1092.11	80.14	0.84	2.10	2.94	1.68	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	567.71	33.92	4.63	2.09	2.54	2.24	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	1041.70	87.01	5.08	1.84	4.90	2.71	2.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	632.87	50.81	6.26	1.47	2.21	0.37	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	513.08	38.35	4.86	2.00	1.43	0.86	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	775.09	36.21	8.42	1.26	1.68	8.84	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	343.87	32.42	4.11	0.00	2.74	1.37	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	396.21	30.69	5.88	0.00	1.79	2.81	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	413.31	24.87	5.50	0.00	3.40	2.09	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	419.61	27.11	3.70	0.31	1.85	0.62	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	406.69	27.30	2.35	0.00	4.00	3.77	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	415.96	26.74	5.42	0.00	3.38	1.02	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	427.55	31.83	3.54	0.00	0.79	2.36	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	413.34	32.44	3.24	0.00	0.46	0.00	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	772.86	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	485.41	36.92	6.35	0.00	2.88	2.88	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	410.95	26.55	4.02	0.00	2.01	2.23	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	471.09	29.56	4.09	0.00	2.16	1.68	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	363.73	25.67	4.40	0.73	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	416.21	32.89	4.70	0.34	2.01	4.03	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	438.03	22.93	5.32	0.00	2.87	1.23	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	427.84	34.36	4.30	0.00	2.15	3.44	3.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	456.65	21.88	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	413.20	15.49	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	390.07	31.18	6.82	0.00	1.62	2.60	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	394.30	37.83	4.36	0.00	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	440.86	31.45	4.80	0.53	1.07	4.80	4.26
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	372.09	25.35	2.45	0.00	1.64	0.82	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	375.12	25.27	3.89	0.00	1.55	2.72	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	360.98	27.28	0.00	0.00	10.49	6.30	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	429.18	20.86	1.99	0.00	0.99	6.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	419.52	23.84	4.77	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	324.35	23.13	4.74	0.00	3.56	2.96	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	398.44	28.02	0.00	0.00	6.09	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	622.21	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	422.47	21.54	3.80	0.00	2.53	5.07	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	281.79	25.18	4.14	0.00	4.48	2.76	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	275.10	30.09	2.15	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	275.43	35.93	11.98	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	230.74	6.89	0.00	0.00	6.89	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	235.93	21.19	3.26	0.00	3.67	0.81	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	216.88	23.04	2.38	0.00	3.97	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	195.72	14.15	4.13	0.00	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	176.11	16.21	2.18	0.00	3.12	0.62	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	181.79	12.03	2.67	0.00	5.35	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	154.93	10.64	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	169.49	7.70	5.14	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	159.71	8.26	2.07	0.00	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	74.22	3.46	1.48	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	62.80	5.61	1.12	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	63.61	6.36	0.64	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	77.37	4.43	1.61	0.00	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	78.50	8.72	4.36	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	69.69	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	58.87	4.86	0.00	0.61	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	90.38	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	68.37	4.94	3.29	0.00	0.00	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	71.83	5.56	0.99	0.00	0.60	0.40	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	93.13	5.52	0.65	0.00	0.00	0.00	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	103.90	3.06	5.09	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	295.56	19.34	3.87	3.09	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	618.72	54.81	15.12	0.94	9.92	1.42	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	791.17	55.83	2.32	0.93	0.70	4.63	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	982.93	72.65	0.00	0.00	0.00	12.82	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	447.48	24.25	2.47	0.21	1.95	3.80	3.80
mesothelioma cell line:Mero-25	10850-111F4	681.09	62.64	1.59	0.68	1.59	2.95	2.04
mesothelioma cell line:Mero-41	10851-111F5	1353.17	100.23	8.31	0.00	1.71	5.38	2.20
mesothelioma cell line:Mero-48a	10852-111F6	2151.42	187.11	16.61	0.44	5.54	6.42	7.97
mesothelioma cell line:Mero-82	10853-111F7	628.63	60.45	3.68	0.00	1.58	3.68	3.42
mesothelioma cell line:Mero-83	10854-111F8	617.22	52.60	5.79	0.00	1.19	5.79	4.09
mesothelioma cell line:Mero-84	10855-111F9	1300.52	74.57	5.31	0.00	1.77	4.04	1.52
mesothelioma cell line:Mero-95	10856-111G1	1179.31	93.17	6.42	0.41	3.11	7.45	9.32
mesothelioma cell line:NCI-H2052	10847-111F1	778.21	67.09	4.80	0.17	3.98	2.15	1.99
mesothelioma cell line:NCI-H226	10846-111E9	1228.57	106.97	3.62	0.54	1.27	3.62	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	724.63	38.09	5.64	0.34	2.39	1.54	1.37
mesothelioma cell line:NCI-H28	10845-111E8	366.43	6.62	5.60	0.00	3.05	2.29	0.51
mesothelioma cell line:No36	10857-111G2	929.68	67.52	9.13	0.00	1.63	2.61	1.96
mesothelioma cell line:ONE58	10858-111G3	799.58	48.23	2.98	0.54	3.79	3.25	4.34
migratory langerhans cells, donor1	11901-125F2	645.82	135.50	0.96	0.00	0.58	5.76	5.18
migratory langerhans cells, donor2	11902-125F3	433.88	96.10	1.22	0.24	0.73	2.08	2.20
migratory langerhans cells, donor3	11903-125F4	541.67	155.97	1.97	0.00	0.54	1.79	2.33
mixed mullerian tumor cell line:HTMMT	10689-109F5	379.70	6.86	3.92	0.00	1.31	13.06	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	606.14	46.84	7.42	1.06	3.39	9.96	2.97
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	150.19	18.20	2.53	0.00	0.23	1.61	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	792.95	147.29	4.76	4.38	2.85	5.14	4.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1158.83	58.58	21.99	0.37	0.74	5.36	2.22
myeloma cell line:PCM6	10474-106I6	186.00	26.88	1.78	0.00	0.40	1.78	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	455.04	22.32	4.57	0.51	4.06	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	607.05	55.51	7.26	0.00	7.65	2.16	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	172.37	17.72	1.56	0.00	2.01	0.33	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	186.28	17.72	1.69	0.22	1.18	0.88	0.29
nasal epithelial cells, donor2	12227-129F4	363.76	33.67	2.21	4.42	1.66	2.21	1.10
neuroblastoma cell line:CHP-134	10508-107D4	7.59	1.38	2.53	0.00	0.00	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	431.04	27.69	13.84	0.94	0.56	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	5.48	0.42	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	30.19	1.68	2.80	0.00	0.00	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	70.93	2.61	10.68	0.24	0.00	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	22.97	1.58	1.11	1.11	0.00	0.95	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	145.31	8.65	9.06	0.00	0.00	1.01	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	55.95	3.18	3.81	1.27	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	512.90	24.22	3.73	0.53	1.06	2.93	1.33
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	225.77	13.28	0.00	53.12	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	198.88	18.94	0.00	56.82	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	270.76	36.02	8.12	1.35	0.68	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	566.76	37.62	24.02	0.00	0.80	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	208.39	19.56	1.28	1.60	2.56	3.85	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	476.39	29.69	3.42	0.26	2.36	4.47	1.05
nucleus accumbens, adult, pool1	10037-101F1	48.46	3.09	0.84	0.00	0.19	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	49.45	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	151.89	4.03	1.61	0.27	0.00	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	210.36	8.01	2.91	0.36	0.00	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	30.96	1.84	0.79	0.00	0.00	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	55.35	2.15	1.72	0.00	0.00	1.72	0.43
occipital pole, adult, pool1	10036-101E9	43.13	2.84	0.95	0.00	0.08	0.08	0.00
olfactory region, adult	10195-103E6	51.97	2.48	0.76	0.00	0.19	0.00	0.57
optic nerve, donor1	10277-104E7	178.09	4.00	2.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	717.62	47.50	5.92	1.03	4.10	3.08	2.51
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	258.70	23.36	5.36	0.69	1.10	0.69	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	669.51	25.91	3.05	0.85	0.17	7.11	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	498.19	39.97	7.16	2.77	2.31	1.16	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	900.71	51.74	10.29	0.59	1.47	7.35	4.41
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	215.83	14.95	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	398.03	28.20	4.67	0.64	1.48	1.06	1.70
ovary, adult, pool1	10020-101D2	232.18	8.65	3.49	0.70	1.22	0.35	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	417.60	32.81	4.40	0.37	2.75	3.30	0.55
pancreas, adult, donor1	10049-101G4	238.92	15.99	6.58	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	100.35	11.74	3.63	0.00	0.00	0.84	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	806.79	25.72	3.41	0.51	1.70	4.94	2.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	518.60	52.66	6.29	2.98	1.49	1.49	1.16
paracentral gyrus, adult, pool1	10035-101E8	41.55	2.56	0.55	0.00	0.09	0.09	0.00
parietal cortex, adult, donor10258	10373-105G4	40.37	1.47	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	47.96	1.88	0.94	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	98.91	2.57	1.43	0.57	0.29	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	36.92	2.11	1.06	0.09	0.18	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	77.59	5.82	1.94	0.00	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	173.10	6.73	4.11	1.12	0.00	0.75	0.00
parotid gland, adult	10199-103F1	165.27	11.10	3.70	0.00	1.23	0.62	0.00
penis, adult	10200-103F2	358.79	17.72	2.15	0.00	1.61	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	206.02	2.79	2.60	0.74	0.19	0.37	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	440.14	32.49	4.95	1.31	0.44	2.48	1.46
pineal gland - adult, donor10196	10179-103C8	80.63	1.29	3.23	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	115.48	7.70	1.78	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	79.64	5.64	0.00	0.63	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	115.35	8.09	0.00	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	69.32	2.61	1.56	0.00	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	37.45	4.26	1.70	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	587.61	31.82	5.81	0.54	2.80	1.40	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	309.22	54.96	4.63	1.19	0.40	1.06	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	867.38	62.72	4.05	2.80	4.67	4.51	3.58
pons, adult, pool1	10033-101E6	68.68	5.34	2.84	0.00	0.17	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	43.94	2.88	0.70	0.00	0.09	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	96.20	8.37	4.18	6.27	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	534.28	5.51	27.54	22.03	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	481.17	11.74	23.47	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	792.98	66.28	27.82	0.73	10.49	5.83	1.02
prostate cancer cell line:PC-3	10439-106E7	687.71	48.64	9.98	0.36	3.09	3.09	1.45
prostate, adult, pool1	10022-101D4	234.08	12.79	2.99	0.09	1.45	0.36	0.45
putamen, adult, donor10196	10176-103C5	40.84	1.18	0.47	0.00	0.00	0.00	0.24
putamen, adult, donor10252	10152-102I8	127.45	5.88	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	80.87	16.39	0.00	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	43.97	4.11	0.00	0.00	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	176.17	6.00	1.50	0.00	0.00	2.25	2.25
rectal cancer cell line:TT1TKB	10469-106I1	118.12	5.24	4.65	0.29	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	269.85	11.13	6.95	1.39	0.00	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	844.60	70.81	13.36	0.64	8.27	6.36	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	343.79	24.02	6.63	0.00	3.31	4.14	2.07
retina, adult, pool1	10030-101E3	160.83	10.14	3.58	0.20	0.99	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	20.52	2.60	3.38	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.12	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	94.20	5.62	0.84	0.84	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	188.71	6.82	0.76	0.00	8.34	0.76	0.00
salivary acinar cells, donor1	11771-123I7	181.93	24.28	2.75	0.16	0.65	1.62	0.97
salivary acinar cells, donor2	11772-123I8	297.27	36.07	2.20	0.28	1.10	1.79	1.79
salivary acinar cells, donor3	11773-123I9	113.21	11.25	1.32	0.66	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	223.06	7.44	1.14	0.00	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	126.38	13.91	3.54	0.17	4.89	0.51	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	100.98	9.29	3.41	0.12	5.29	0.47	0.35
seminal vesicle, adult	10201-103F3	359.24	13.76	2.65	0.00	0.00	2.12	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	689.91	24.05	7.53	2.19	2.43	3.89	3.89
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	905.62	56.37	6.79	3.52	2.01	2.52	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	1668.87	83.29	8.03	7.02	5.02	8.03	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	704.11	38.82	7.12	0.13	2.96	2.15	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	366.40	32.72	4.75	0.33	1.22	0.55	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	320.24	22.84	2.97	0.00	1.03	2.06	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	93.63	4.97	0.00	0.00	0.00	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	176.79	11.03	2.28	0.00	1.32	0.36	0.36
skeletal muscle, fetal, donor1	10066-101I3	194.97	5.03	4.02	0.00	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	393.54	27.14	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	293.52	10.10	1.89	5.05	0.63	6.31	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	427.58	43.02	16.68	3.34	4.34	5.00	2.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	363.75	33.73	7.25	1.58	3.47	2.84	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	15.23	0.77	5.78	0.00	0.00	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	359.16	42.36	6.26	0.66	1.32	0.82	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	199.29	19.14	8.36	0.32	0.16	1.45	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	353.46	41.40	10.24	1.09	0.65	0.65	0.44
small intestine, adult, pool1	10024-101D6	492.22	23.89	6.33	0.36	1.07	2.03	2.03
small intestine, fetal, donor1	10064-101I1	329.97	8.11	5.41	0.00	0.74	2.95	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	852.44	42.57	12.31	2.56	2.56	10.26	4.10
smooth muscle, adult, pool1	10048-101G3	164.12	7.75	1.81	0.52	0.52	1.55	0.26
somatostatinoma cell line:QGP-1	10781-110G7	112.03	14.47	4.82	0.00	0.27	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	130.07	3.67	2.29	0.00	0.23	1.38	0.69
spinal cord, adult, donor10252	10159-103A6	138.78	7.49	1.58	0.00	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	94.08	6.92	0.69	0.00	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	143.92	4.88	4.27	0.00	0.00	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	236.49	9.64	1.38	0.46	0.92	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	472.41	30.92	6.12	0.60	2.39	1.79	0.45
spleen, adult, pool1	10025-101D7	479.52	25.00	6.50	0.44	1.54	1.43	1.43
spleen, fetal, pool1	10044-101F8	586.06	33.77	3.97	1.43	1.27	0.87	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	472.53	73.70	6.62	1.24	0.72	0.93	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	398.17	31.90	4.56	0.57	0.76	1.71	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	607.35	32.50	4.89	0.35	1.05	7.34	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	554.73	41.83	3.13	0.00	0.39	2.35	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	311.34	17.22	3.26	0.45	1.91	0.79	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1127.20	56.76	6.35	0.00	0.42	1.69	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	377.38	30.46	5.92	0.00	2.54	1.69	0.00
stomach, fetal, donor1	10062-101H8	752.92	24.56	2.14	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	236.99	16.52	3.99	0.00	0.00	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	157.86	8.72	2.70	0.21	0.42	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	90.00	11.38	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	197.84	4.24	1.41	0.00	0.71	0.71	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	97.21	7.34	9.40	0.00	0.00	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	53.74	4.07	2.12	0.00	0.17	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	95.44	7.12	1.42	0.00	0.71	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	184.61	12.75	2.64	0.00	0.44	0.00	0.44
tenocyte, donor1	11763-123H8	681.10	58.65	2.44	0.35	5.24	5.93	1.05
tenocyte, donor2	11765-123I1	602.40	41.97	3.05	0.00	4.96	3.05	0.38
tenocyte, donor3	11768-123I4	571.94	38.55	3.71	0.00	3.71	3.34	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	245.93	23.62	3.74	0.51	1.19	1.02	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	198.70	20.04	6.17	1.08	0.00	2.77	1.70
teratocarcinoma cell line:PA-1	10807-111A6	277.41	28.36	9.92	0.77	0.77	0.93	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	565.93	37.96	5.97	0.38	0.63	8.12	11.04
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	298.76	29.88	3.03	0.00	0.38	1.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	423.82	26.17	2.18	0.55	1.42	1.42	1.85
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	651.08	54.07	1.63	0.65	0.65	6.84	2.93
testis, adult, pool1	10026-101D8	303.54	18.47	3.11	2.15	2.68	1.29	3.44
testis, adult, pool2	10096-102C6	391.09	27.97	3.16	0.90	0.45	0.45	0.45
thalamus - adult, donor10196	10168-103B6	71.76	5.52	0.00	0.00	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	142.53	5.63	1.72	0.00	0.00	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	83.14	13.86	0.00	1.54	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	65.38	3.13	0.99	0.00	0.66	0.99	1.15
thalamus, newborn, donor10223	10366-105F6	86.87	1.15	0.58	0.00	0.00	0.58	0.58
throat, adult	10209-103G2	396.48	22.97	1.50	0.50	1.25	2.50	1.75
throat, fetal, donor1	10061-101H7	217.86	9.14	3.96	0.91	0.61	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	113.08	3.78	6.96	0.00	0.00	0.40	0.20
thymus, adult, pool1	10027-101D9	312.56	27.34	4.77	1.59	0.10	1.09	1.49
thymus, fetal, pool1	10043-101F7	347.66	31.48	3.74	1.45	0.73	1.14	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	1047.86	65.15	7.18	0.80	6.52	5.32	4.12
thyroid carcinoma cell line:TCO-1	10783-110G9	645.79	45.12	8.10	1.26	2.37	2.51	1.68
thyroid, adult, pool1	10028-101E1	223.11	11.48	4.20	0.09	0.47	0.93	0.56
thyroid, fetal, donor1	10060-101H6	199.86	8.70	4.75	1.05	1.05	1.85	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	409.59	12.32	0.00	0.00	3.08	0.00	3.08
tongue, adult	10203-103F5	694.48	43.96	3.02	0.47	0.93	3.72	3.26
tongue, fetal, donor1	10059-101H5	396.46	18.52	2.76	0.79	1.58	4.73	1.58
tonsil, adult, pool1	10047-101G2	478.84	38.17	4.61	0.30	0.70	1.00	0.30
trachea, adult, pool1	10029-101E2	563.10	33.46	3.44	2.13	2.86	1.31	0.82
trachea, fetal, donor1	10058-101H4	307.37	16.93	2.69	1.54	1.15	2.69	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	459.85	31.88	6.38	0.71	4.61	2.83	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	643.46	38.91	8.41	0.61	2.43	2.23	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	291.91	23.82	12.85	0.16	4.39	5.33	5.48
tridermal teratoma cell line:HGRT	10694-109G1	110.35	3.81	7.61	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	88.04	9.99	3.39	0.17	0.51	0.34	0.85
umbilical cord, fetal, donor1	10057-101H3	239.95	20.87	0.00	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	257.99	17.75	0.85	0.51	2.73	0.51	0.85
uterus, fetal, donor1	10055-101H1	260.06	10.24	4.61	0.51	0.51	2.56	1.02
vagina, adult	10204-103F6	295.31	7.75	0.00	0.65	0.65	0.65	1.29
vein, adult	10191-103E2	447.60	23.67	3.73	0.44	0.88	1.97	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	352.76	72.63	6.68	0.80	0.27	1.34	0.53